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 SUMMARY 
Achieving content uniformity for low dose tablet formulations can present 
several processing and formulation challenges. The uniformity of the starting 
powder blend constitutes the first step in ensuring content uniformity of the 
tablets. Traditionally, quality assessments of tablets and their intermediates are 
based on tests conducted on limited samples. However, the samples obtained 
are rarely representative of the production batch. Furthermore, the analyses of 
excipients have been neglected. This project comprised two main parts 
concerned with the low dose tablet manufacturing. The first investigated the 
role of excipient (lactose) surface roughness in ordered mixing and physical 
stability of the ordered mixture. Surface roughness of lactose particles showed 
significant influence on bulk powder flow and capacity to retain drug particles 
on their surfaces. The second dealt with in-line monitoring of blending and 
tabletting unit operations using near infrared (NIR) spectroscopy. Findings of 
this study showed that with the unique features of NIR spectroscopy, i.e. high 
speed sampling and rapid spectral acquisition, simultaneous distribution of 
both drug and excipients could be monitored with high accuracy in an efficient 
and non-destructive manner. This would not have been possible with 
traditional content uniformity analysis. Findings of this project represent a step 
forward in achieving the objectives of continuous quality improvement of 
pharmaceutical dosage forms as laid out by US-FDA process analytical 
technology (PAT) guidelines. 
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GLOSSARY OF TERMS 
D-optimal mixture design: is an experimental design involving three or more 
mixture variables and at lest one process variable. In this design, multi linear 
relationship can be defined between mixture variables and/or between process 
variables.    
Simplex lattice design: is a mixture design with a simplex shaped 
experimental region.  
Validation: allows checking how well a model will perform for future samples 
taken from the same population as the calibration samples. 
Cross validation: is a validation method where some samples are kept out of 
the calibration and used for prediction. This is repeated until all samples have 
been kept out once. In segmented cross validation, the samples are divided 
into subgroups or segments. One segment at a time is kept out of the 
calibration. This is repeated until all segments have been kept out once. In full 
cross validation, only one sample at a time is kept out of the calibration. 
Bias: is a systematic difference between predicted and measured values. It is 
computed as the average value of residuals.   
Correlation: is a unit-less measure of the amount of linear relationship 
between two variables. It varies from -1 to +1.   
Residual: is a measure of the variation that is not taken into account by the 
model. The residual for the given sample and a given variable is computed as 
the difference observed value and fitted (or projected, or predicted) value of 
the variable on the sample.  
 Root mean square error of calibration (RMSEC): is the measurement of the 
average difference between predicted and measured response values, at the 













 1. INTRODUCTION  
Drug product development is a process of transforming a drug candidate into a 
drug product which involves pre-clinical studies, clinical studies and 
commercial product development. For a successful transformation of a drug 
candidate into a drug product, certain prerequisites are necessary to be 
satisfied such as: it should be clinically efficacious, safe, bio-available, stable 
and capable of producing desired pharmacological effects, and can be 
manufactured consistently with the identity, strength, quality and purity it is 
represented to possess. During development of a drug product, especially oral 
solid dosage forms, dose strength is one of the critical product attributes that 
may have a significant impact on formulation and analytical development. In 
particular for low dose oral solid dosage forms, pharmaceutical scientists face 
considerable difficulties in formulation, manufacture, analytical chemistry, 
and regulatory requirements (Zeng, 2009).  
In recent years, the pharmaceutical industry has introduced a number of low 
dose drug products. Drug products (dosage forms) include tablets, hard gelatin 
capsules, and soft gelatin capsules. These products generally contain single or 
multiple drugs. There are many therapeutic areas which involve usage of low 
dose drug products (Physicians desk reference, 2006) such as 
antihypertensive, anti-histaminic, anti-asthmatic and many more.  
1.1. Manufacturing platforms for low dose drug formulations 
The most commonly used manufacturing platforms for solid dosage forms 
include, granulation (high shear wet granulation, fluid bed granulation, melt 
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 granulation), direct compression, roller compaction. Each manufacturing 
platform has its unique characteristics and complexity in terms of unit 
operations. Since more than one platform technology can be used to 
manufacture a drug product, selection of the most appropriate manufacturing 
platform is imperative. This is influenced by many factors such as: 
 Physical, chemical and biopharmaceutical properties of the drug 
substance 
 Dose of the drug  
 Cost and development duration 
 Critical product quality attributes 
 Process and in-process control strategy 
 Capabilities at the manufacturing facilities  
 Scale up and technology transfer at the manufacturing factories. 
One of the most important quality attributes for low dose drug products is 
uniformity of dose units. Thus, the dose strength in the drug product is an 
important consideration in the selection of the manufacturing platform 
technology. A simple decision tree on platform technology selection according 
to dose strength is described in Figure 1. As can be seen from the decision 
tree, if the drug substance can be micronized, roller compaction and/or direct 
compression could be the appropriate choice of manufacturing platform for the 
formulations containing more than 0.5 mg drug. Direct compression and roller 
compaction offer economic advantages through elimination of intermediate 
granulation and drying steps. Moreover, these platform technologies are 
suitable for drug substances which have physical and chemical stability 
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 problems when exposed to moisture and temperature. As mixing is the key 
unit operation, production of a homogenous blend with fewer tendencies to 
segregate by careful selection of excipients and optimization of the 
formulation and manufacturing process, is a crucial step. In an ideal situation, 
ordered mixing by design can offer good blend uniformity required in direct 
compression or roller compaction.  
Although the development of normal-dose and low dose drug products follows 
a similar path, the increase in potency and decrease in dose amount with low 
dose drug products create a number of challenges. In particular, 
pharmaceutical scientists and production operators must meet the stringent 
regulatory standards required for formulation, manufacturing and analysis of 
low dose formulations. According to 21 CFR-211.110(a), pharmaceutical 
manufacturers are legally required to demonstrate the adequacy of mixing to 
ensure uniformity of in-process powder blends and finished dosage units. 
Consistency of dosage units requires the preparation of a homogenous powder 






Figure 1: Solid oral formulation decision tree for low dose drug product. 
(Adapted from “Jack Zeng. (Ed.), Formulation and analytical development of 
low dose oral drug products, Wiley”). 
1.2. Challenges in formulating low dose drug formulations 
A low dose formulation is likely to have a very high ratio of excipients to drug 
substance. These characteristics present many hurdles during formulation and 
process development, including: 
 Difficulty in achieving content uniformity due to low drug 
concentration;  
 Low potency due to manufacturing loss; 
 Physical instability due to huge ratio of excipients to drug;  
 Chemical instability due to micronized drug having greater surface 
exposure to excipients, moisture, and manufacturing equipment; 
 Difficulty in developing analytical methods to determine blend and 
content uniformity. 
From the perspective of a formulator, the uniformity of the starting powder 
blend constitutes the first step in ensuring content uniformity of the final drug 
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 product. This raises two main questions: How to achieve an acceptable 
uniformity of the final blend? How to demonstrate or test the blend 
uniformity? 
1.2.1. How can uniformity of the final blend be achieved? 
Most of the platform technologies for manufacturing oral solid dosage forms, 
such as high shear wet granulation, fluid bed granulation, dry granulation, and 
direct compression, involves a mixing process as one of the important unit 
operations. Low dose drugs often pose difficulties in achieving homogenous 
mixing with the inert ingredients. A possible approach to overcome this 
problem is reduction of the particle size of low dose drugs, so that they can be 
dispersed more readily. Micronization increases the surface area and surface 
energy, thus creating cohesiveness between the drug particles. This 
cohesiveness often promotes aggregation and agglomeration. Such 
agglomerated drug particles need to be broken down for efficient mixing. 
Ordered mixing (Hersey, 1975) is generally carried out to overcome this 
problem. Micronized drug is mixed under high shear with one of the major 
and relatively coarse excipient in the formulation to facilitate the de-
agglomeration of drug particles and their simultaneous adhesion or coating 
over the surfaces of the coarse excipient particles (Yip and Hersey, 1976). The 
adhesional forces involved may be electrostatic or surface tensional. Such 
systems are capable of giving homogenous mixtures and also offer significant 
advantages in the manufacture of solid dosage forms in particular, those 
containing lower quantities of drug if carried out under appropriate conditions. 
The fine drug particles result in higher dissolution rates and the coarse 
excipient particles give the mixture the required characteristics for tabletting.  
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 1.2.1.1. Factors affecting ordered mixing  
De-agglomeration of the micronized drug is an important prerequisite for 
successful ordered mixing. A number of factors could be traced as important 
for de-agglomeration of micronized drug particles. 
 Physicochemical properties of the drug and excipients 
The size of carrier particles controls the size of the single ordered unit, and 
therefore the level of segregation and the homogeneity of the mixture. A 
homogenous carrier particle size, i.e. narrow particle size distribution, ensures 
a satisfactory flow for the blend and avoids the potential segregation. 
Generally, more free flowing diluents facilitate faster mixing, which is 
attributed to their abrasive properties acting mechanically to disperse the 
agglomerated drug. Drug tensile strength and flow properties may also 
indicate the magnitude of the energy required to disperse agglomerates. Cheng 
(1968) suggested that the tensile strength of powders is a function of density, 
particle size distribution and inter-particulate forces. 
 Particle morphology of excipients 
Besides particle size and drug concentration, particle morphology is also 
important for achieving a homogenous mixture. Powders comprising nearly 
spherical particles are easier to mix than those with irregular shaped particles. 
Micronized, needle shaped, or flat particles require longer blending time due 
to agglomerate formation. Macro-porous or rough surfaced carriers have better 
inter-particulate interactions with fine particles. Kornchankul et al. (2002) 
determined that certain particle shapes, such as that of microcrystalline 
cellulose (MCC), affected flow and caused bridging. Poor flow of the blend 
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 was detrimental to uniform die filling, and therefore resulted in higher 
variability in content uniformity. These interactive mixing methods rely on 
drug particles interacting more favorably with excipients than with other drug 
particles, balancing drug agglomerate formation with cohesive interaction. 
 Processing conditions used for mixing 
Except for wet and melt granulation, ordered mixing of fine and low dose drug 
particles with coarse excipients is a common prerequisite before proceeding to 
the next unit operation. This mixing process is usually carried out in different 
ways. For example: with fluid bed granulation, the drug particles are premixed 
using high shear mixer or cone mill, or in the product chamber of the fluid bed 
granulator itself; whereas in slugging and roller compaction, high shear 
mixing or cone milling is usually preferred. Overall, the purpose of premixing 
is to achieve the breakdown of agglomerates into the smaller primary particles 
and to facilitate their coating onto the surfaces of coarse excipients. This unit 
operation is highly recommended for low dose formulations in order to 
achieve the required blend and content uniformity, and consequently a 
consistent and efficacious drug product. With very low drug concentrations, 
geometric dilution or trituration become less effective for de-agglomeration. 
Several methods are used in the pharmaceutical industry for efficient de-
agglomeration, such as: a) sieving a mixture of micronized drug and filler-
binder, b) milling a mixture of micronized drug and filler-binder and c) using 
high shear mixing.  
It is important to understand the nature of the agglomerates to be dispersed. If 
the agglomerates are only held together by cohesive surface forces, the above 
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 mentioned techniques have a good chance to work. If the agglomerates are 
bound together tightly, a more aggressive milling approach may be needed.  
Sieving drug-filler premixes is a simple unit operation and, in many cases, is 
an adequate approach to limiting agglomerates to a subcritical level. The 
appropriate mesh size for sieving a premix is also important. Choice of mesh 
size depends substantially on the drug dose strength and required degree of 
homogeneity, and can be determined only by approximation. It is estimated 
that reducing the maximum agglomerate weight to 5% of the labeled drug 
content is adequate based on the requirements of the United State 
Pharmacopeial (USP) content uniformity test.    
An alternative approach to sieving for de-agglomeration is to mill the drug-
filler pre-blend using a cone mill. This approach could easily work at a 
commercial scale. A 1% blend of red iron oxide (nominal size of 2 μm) in 
spray dried lactose (mean size of 100 μm) required two passes through the 
cone mill using the smallest screen at 1400 rpm to effectively de-agglomerate 
the pigment (Poska et al., 1993). 
Another example focuses on blending a cohesive drug using rotating bins of 
different sizes, followed by passing the blend through a conical cone mill after 
discharge from the rotating bin. The conical mill provides shear and ensures 
that the blend will be entirely and uniformly exposed to shear. Conical mills 
improve the distribution of the drug substance and minimize the occurrence of 
drug agglomerates. However, use of mills which lacks back mixing capacity is 
not always the perfect solution, particularly when the blend is highly 
heterogeneous. The milled product will again exhibit certain differences in 
composition. However, for low dose formulation development, milling can 
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 still be effective since an additional mixing unit operation with the remaining 
filler-binders (90 %) occurs after this unit operation.  
Among the different de-agglomeration techniques discussed, high shear 
mixing is advantageous over lower shear mixing for distribution, high 
intensity mixing, and de-agglomeration of drug particles within the same unit 
operation.   
1.2.2. How can uniformity be demonstrated or tested? 
As mentioned earlier (Section 1.1), demonstration of the adequacy of mixing 
to ensure uniformity of in-process powder blends and finished dosage units is 
a legal requirement. Traditionally, pharmaceutical powder blending processes 
are optimized during development in such a way as to stop the process when 
the mixture homogeneity is within a pre-defined specification regarding its 
active content uniformity. 
Most of the traditional approaches to assess powder blend homogeneity are 
time consuming and hampered by sampling errors since they involve the 
removal of unit-dose samples from defined mixer locations using a sampling 
thief, extraction of the active drug from the sample matrix, and drug content 
analysis by either high performance liquid chromatography (HPLC) or ultra-
violet (UV) spectroscopy. Despite the simplicity in their operation, sampling 
thieves suffer from serious drawbacks owing to the errors associated with 
using these devices for sampling powder mixtures, which can significantly 
bias the blend homogeneity results. A wide array of information can be found 
in the literature published previously regarding the drawbacks associated with 
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 the sampling thief (Harwood and Ripley, 1997; Berman et al., 1996; Chang et 
al., 1998).  
In the traditional pharmaceutical sense, blend homogeneity addresses only the 
distribution, i.e. the content uniformity of the active drug substance while 
assuming that the excipients are also evenly distributed. Low dose 
formulations have a very high ratio of excipient/s to drug. Therefore, the 
quality and quantity of the excipients is vital to ensure the quality of the 
finished dosage forms. Conventionally, distribution of individual excipients is 
typically assumed to be homogeneous if the active ingredient is uniformly 
distributed. The role of the excipients, which not only improve and affect 
dosage form compliance, but also the technological and biopharmaceutical 
performance of the formulation, is simply neglected.  
The United States Food and Drug Administration (FDA) issued guidelines 
from time to time suggesting that commercial batch final blends and dosage 
units should be routinely tested for homogeneity. The FDA’s principle was to 
ensure that high quality was maintained throughout the different production 
processes and not just demonstrated in the final dosage form. These routine 
testings were observed to be problematic and not necessary, provided that 
adequate process validation and current Good Manufacturing Practice (cGMP) 
controls are well established (Berman et. al., 1997). Henceforth, FDA 
suggested that “firms should seek alternative procedures to evaluate the 
adequacy of mixing and blend homogeneity when standard sampling 
procedures do not appear capable of providing reliable results”. In September 
2004, as a part of this development, FDA issued its guidance for the 
pharmaceutical industry regarding the implementation of Process Analytical 
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 Technology (PAT) tools. In this guidance, the agency encouraged 
pharmaceutical manufacturers to voluntarily develop and implement new 
technologies in pharmaceutical production and quality control for real time 
measurements of critical product and process parameters. PAT implies 
building quality into products through better understanding and control of the 
manufacturing process, rather than merely testing the quality of the end 
product. It has stressed the usage of at-line, on-line or in-line measurements 
and several recommendations have been proposed to replace the conventional 
methodologies for obtaining samples and their analysis (FDA, 2003; FDA, 
2004). Therefore, development of alternative methods which enable 
uniformity analysis of blend components in a non-destructive, non-invasive 
and real time basis has become an issue of interest in both the academia and 
pharmaceutical industry. Several non-invasive and non-destructive methods 
have been investigated by researchers, such as use of radioactive tracers 
through the bed of non-radioactive tracers (Harwood, 1977), image analysis 
based on color difference of constituent particles (Lim et al., 1993), 
fluorescence microscopy (Staniforth and Iveson, 1986), light induced 
fluorescence (Lai et al., 2001; Harwood et al., 1972), light reflectance 
(Weinekotter and Reh, 1994), thermal effusivity (Leonard et al., 2008; 
Mathews et al., 2002), Raman spectroscopy (De Beer et al., 2008; Vergote et 
al., 2004) and near infrared (NIR) spectroscopy (Hailey et al., 1996; Sekulic et 
al., 1998; Wargo and Drennen, 1996; Patel et al., 2000; Ufret and Morris, 
2001; Berntsson et al., 2002; Shi et al., 2008; Abatzoglou et al., 2008;  Sulub 
et al., 2009). Among these methods, NIR spectroscopy has received 
considerable interest within the pharmaceutical industry and is being 
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 extensively studied owing to a multitude of merits associated with this 
technique.  
1.2.2.1. Near infrared (NIR) spectroscopy  
NIR spectroscopy is a fast and non-destructive technique that provides multi-
constituent analysis of virtually any matrix. The NIR region is situated 
between the red band of the visible light and the mid infrared region. The 
American Society of Testing and Materials (ASTM) defines the NIR region of 
the electromagnetic spectrum as the wavelength range of 780-2526 nm 
corresponding to the wave number range 12820-3959 cm-1. The NIR spectrum 
is a consequence of absorbance of light due to molecular vibrations (overtones 
and combinations of fundamental vibrations) of hydrogen bonds like C-H, N-
H, O-H. Historically, the discovery of the NIR region is ascribed to Herschel 
who separated the electromagnetic spectrum with a prism and found out that 
the temperature increased markedly towards and beyond the red, i.e. in the 
region that is now called the near infrared. 
Although a number of NIR experiments were carried out in the early 1920s, it 
was not until the mid to late 1960s that NIR spectroscopy was practically used. 
Karl Norris was the first scientist to introduce “Modern NIR spectroscopy” 
into industrial practice. It was his pioneering work that recognized NIR 
spectroscopy as an industrial quality control and process control tool with the 
help of chemometrics and development of advanced spectrophotometer 
configurations based on fibre optic probes. In recent years, NIR spectroscopy 
has gained wide acceptance within the pharmaceutical industry for raw 
material testing, product quality control and process monitoring. The growing 
pharmaceutical interest in NIR spectroscopy is probably a direct result of its 
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 major advantages over other analytical techniques, such as ease in sample 
preparation without any pretreatments, possibility of remote sampling with the 
aid of fibre optic probes and prediction of chemical and physical 
characteristics from one single spectrum.  
Like every other technique, NIR spectroscopy also has some drawbacks. For 
instance, due to its high detection limits, the technique is not suitable for trace 
analysis. The main difficulty of the technique is the complexity of the spectra 
which often consist of overlapping absorption bands. This makes it difficult to 
obtain relevant information about the feature of interest using measurements at 
only one wavelength from raw spectra as is the case for UV 
spectrophotometric or colorimetric determinations. Moreover, physical 
conditions of sample and measuring environment also influence the spectra, 
making it even more complex to interpret the data.  Hence, to perform 
qualitative and quantitative NIR spectroscopy analysis, i.e. to relate spectral 
variables to properties of the analyte, mathematical and statistical methods 
(i.e. chemometrics) are required that extract the “relevant” information and 
reduce irrelevant information, i.e. interfering parameters (Martens and Naes, 
1991; Naes, 2002). Three main techniques used in chemometrics are as 
follows:  
 Mathematical pre-processings 
Interfering spectral parameters, such as light scattering, path length variations 
and random noise, resulting from variable physical sample properties or 
instrumental effects, call for mathematical corrections known as spectral pre-
processings prior to multivariate modeling in order to eliminate or standardize 
their impact on the spectra.  Since careful selection of pre-processings can 
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 significantly improve the robustness of a calibration model, it is imperative to 
select appropriate pre-processings. Most commonly used classical pre-
processings are normalizations, multiplicative scatter correction (MSC), 
standard normal variate (SNV), derivatives and smoothing.     
 Multivariate classification for qualitative analysis 
In this analysis, sample properties that have to be related to spectral variations 
have discrete values that represent a product identity or a product quality, for 
example “good” or “bad”. To solve the selectivity and interference problems 
of NIR spectra, multivariate classification methods are used for grouping 
samples with similar characteristics. These methods, also known as pattern–
recognition methods, are subdivided into “non-supervised” and supervised” 
methods, depending on whether or not the class to which the samples belong is 
known.  
Non-supervised methods: Also known as cluster analyses. These methods do 
not require any prior knowledge about the group structure in the data, but 
instead produce the grouping, i.e. clustering, itself. This type of analyses is 
often very useful at the early stage of an investigation to explore sub-
populations in a data set, for instance different physical grades of a material. 
Cluster analyses can be performed with simple visual techniques such as 
principal component analysis (PCA) or some hierarchical methods leading to 
dendrograms.        
Supervised methods: Also known as discriminant analyses. These methods 
are used to build classification rules for a number of pre-specified sub-groups 
where the group structure of the training set is known. The classification rules 
are later used for allocating new or unknown samples to the most probable 
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 sub-group. Identity or good/bad quality are, thus, defined as belonging to a 
group with known properties. Algorithms of this type such as linear 
discriminant analysis (LDA), quadratic discriminant analysis (QDA), soft 
independent modeling of class analogies (SIMCA) or K nearest neighbors 
(KNN) are typically used for constructing libraries. 
 Multivariate calibration (MVC) for quantitative analysis  
To employ NIR spectroscopy as a tool for quantitative analysis, it is necessary 
to assign the spectral data some reference values using established reference 
methods. In other words, spectral information needs to be calibrated using 
multivariate methods (chemometric algorithms) before the NIR spectrometer 
can do any quantitative analysis. Multivariate calibration (MVC) often called 
multivariate modeling involves relating two sets of data, X (spectra) and Y 
(reference values). Thus, optimum MVC models can be generated and may be 
used for prediction or classification after validation (Martens and Naes, 1989). 
A systematic approach for generating the optimal MVC models usually 
involves a set of different steps, viz. appropriate selection of the representative 
calibration samples, spectral acquisition of the samples and their training with 
the reference values (usually determined using traditional standard methods) 
followed by subjecting spectral information to multivariate analysis in order to 
build an optimal MVC model to correlate the spectral variation to the 
reference values. Finally, validation of prepared models with appropriate 
techniques is required to be carried out with appropriate validation techniques 
such as cross validation, leverage correction or external test set validation. 
Principal component regression (PCR), partial least square (PLS) regression 
and multiple linear regression (MLR) can be used as different regression 
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 techniques to build quantitative MVC models (Mark, 1991; Esbensen, 2001). 
The calibration and the validation samples have to be independent and must be 
composed of samples from different batches. Once the MVC model has been 
built and validated, it can be used for routine analysis. Calibration and 
prediction statistics of a model can be evaluated according to the following 
criteria: low residual standard error of calibration (RMSEC), low residual 
standard error of prediction obtained after cross validation (RMSECV), low 
residual standard error of prediction after test set validation (RMSEP), high 
correlation coefficient (R2), and low bias. The formulae and statistical strategy 
are described by Naes et al. (2002). 
Sample selection for calibration and validation sets 
While preparing NIR spectroscopic MVC models, it is critical to obtain 
calibration samples that are both relevant and representative of the real time 
samples that the model will be applied to (Martens and Naes, 1991). The 
representative samples here mean that not only must the calibration sample 
states cover the range of samples expected during operation of the analyzer, 
but the distribution of the calibration sample states should also be sufficiently 
representative of the actual process (Blanco et al., 1997; Kalivas, 2001; Blanco 
et al., 2004). It warrants that all potential sources of variability, such as 
variability in formulation aspects (e.g. concentration range of all the 
formulation components), variability in physical properties (e.g. particle size, 
shape) and other sources of variability resulting from the actual operation of 
the process (e.g. blending, drying, and compression) should be included in the 
calibration samples. In the preparation of MVC models, it is often difficult to 
17 
 
 obtain calibration samples that are both highly relevant and representative. 
Some common strategies employed to obtain the calibration samples include: 
i) laboratory synthesized calibration samples analyzed on a laboratory 
analyzer, ii) laboratory synthesized calibration samples (such as simulated 
physical mixtures) and analyzed on an actual process analyzer, iii) calibration 
samples obtained from the actual process analyzed on a laboratory analyzer, 
and iv) calibration samples obtained from the actual process and analyzed on 
an actual process analyzer (Miller, 2005). These strategies are being 
commonly used as routine methods for obtaining calibration samples. 
However, there are some paradoxical sampling issues associated with the 
adoption of these strategies. For example, the laboratory synthesized 
calibration samples are highly accurate, but they do not represent the state of 
samples during actual processing. The samples obtained from the process 
stream are representative of the actual process samples. Nevertheless, the 
analysis of these samples using laboratory techniques suffers from biases and 
variability due to complicated sample pre-treatments and differences in sample 
handling. Likewise, analysis of samples obtained from the actual process using 
an actual process analyzer may prove to be reason for inaccurate assignment 
of reference values. Design of experiment (DOE) could be used as another 
potential alternative to impart maximum possible relevancy and/or 
representative formulation and process features. Often, DOE needs a large 
number of runs in order to incorporate sufficient degree of variability in the 
calibration samples, which could incur considerable time and capital cost. For 
example, for quantitative modeling, the use of blends or tablets with an 
extended range of active concentrations in the calibration step is required for 
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 the preparation of robust and more accurate MVC models. However, this is 
not a feasible option in the industrial context (Blanco et al., 1996) as tablet 
production batches with extended range of active concentrations are quite rare 
events, reason being the tight tolerances practiced during the whole 
manufacturing process. In an effort to save capital, preparation of laboratory 
synthesized calibration samples which are usually very accurate may be 
employed as the method of choice. However, apart from formulation centered 
variability, it fails to incorporate process features which are more detrimental 
to successful application of MVC models for future predictions of samples 
from the process stream.  
Although a number of techniques have been adopted to obtain accurate and 
representative calibration samples, this sampling paradox has not been 
subjected to great attention. For example, in the field of dry powder blending, 
most of the studies carried out so far have used either laboratory synthesized 
calibration samples (Ufret and Morris, 2001; Berntsson et al., 2002; Duong et 
al., 2003; Li and Worosila, 2005;Li et al., 2006; Benedetti et al., 2007; Sulub 
et al., 2009) or samples obtained from the process stream and analyzed off-line 
to build MVC models (Popo et al., 2002; El-Hagrasy and Drennen III, 2006; 
Shi et al., 2008; Wu et al., 2009). These models were then used for on-line / 
in-line predictions or process analysis. 
Recent studies carried out in this field emphasized on the prediction of blend 
components using NIR spectroscopy and MVC models. Wu et al., (1996) 
made a study on the influence of sample selection in the sets on neural 
networks models. In one of the classic papers, Moffat et al. studied this issue 
and suggested various options for proper calibration sample selection (Moffat 
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 et al., 2000). In the same paper, the authors provided suggestions on how to 
meet the International Conference on Harmonization (ICH) guidelines on 
validation for NIR quantitative analysis of active ingredients in tablets. 
Validation of quantitative NIR methods has also been addressed by Blanco et 
al. (1999; 2000). However, none of them have addressed the issue of sampling 
paradox for multi-component blends using in-process spectral acquisition of 
calibration samples. 
Determination of reference values 
Finding the composition of standard samples is not a problem when using 
synthetic mixtures for calibration. Samples that are not synthetic and that are 
characterized as complex in nature must be analyzed using an accepted or 
authorized chemical procedure prior to calibration. Random error within the 
chemical data must be reduced to the minimum possible level in order to 
perform the optimum calibration. Error in the chemical data (laboratory) 
cannot be removed mathematically but it can be reduced by using the average 
composition as determined by replicate chemical measurements for each 
sample. Generally, calibration samples are prepared by assigning the reference 
values obtained from laboratory methods, such as HPLC or UV or mass 
balanced (gravimetric) methods, to the powder blend.  
However, similar assignments are not useful for NIR spectroscopy because the 
effective sample mass per unit area is not only a function of physicochemical 
properties of the powder sample but also of the wavelength and depth of 
penetration of the NIR radiation (Berntsson et al., 1998). Moreover, in multi-
component mixtures, materials may be homogenous with respect to one 
property but heterogeneous with respect to another. There is a possibility of 
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 some variations in the composition of random samples drawn from a powder 
mixture. In such situation, it becomes questionable to arbitrarily assign 
reference values obtained by the HPLC or UV methods to the NIR spectra 
collected from the bulk powders. Instead, it is recognized that averaging the 
spectra from an appropriate number of sub-fractions of the same powder 
sample should be more representative of the actual reference value of the 
chemical content in the entire powder sample (Berntsson et al., 2000). 
Multivariate modeling of spectra and the reference values  
The MVC model for (X, Y) is simply a regression relationship between the 
empirical (X, Y) relations:  X + Y = MODEL. 
The regression model is then used on a new set of X measurements for the 
specific purpose of predicting new Y values. In NIR spectroscopy, the 
regression models are generally built using MLR (multiple linear regression), 
PCR (principal component regression), and PLS (partial least square) 
regression. The complete discussion of these methods is out of scope in the 
context of this thesis. However, a brief description is provided for ease of 
understanding in the following paragraphs (Martens and Naes, 1991; Naes, 
2002).  
Multiple linear regression (MLR) is an extension of simple linear 
regression with more than one dependent variable. It relates the variations in a 
response variable (Y) to the variations of several predictors (X), with 
explanatory or predictive purposes. An important assumption for the method is 
that the X variables are linearly independent, i.e. that no linear relationship 
exists between the X variables.    
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 Principal component regression (PCR) is a two step regression method. In 
the first step, a principal component analysis (PCA) is carried out on the X 
variables. The principal components are then used as predictors in a multiple 
linear regression.  PCA involves a mathematical procedure that transforms a 
number of possibly correlated variables into a smaller number of uncorrelated 
variables called principal components. The first principal component accounts 
for as much of the variability in the data as possible, and each succeeding 
component accounts for as much of the remaining variability as possible.  
Partial least square (PLS) regression is a method for relating the variations 
in one or several response variables (Y variables) to the variations of several 
predictors (X variables). PLS regression is a bilinear modeling method where 
information in the original X variables are projected onto a small number of 
underlying (“latent”) variables called PLS components. The Y variables are 
actively used in estimating the “latent” variables to ensure that the first 
components are those that are most relevant for predicting the Y variables. 
Interpretation of the relationship between X and Y variables is then simplified 
as this relationship is concentrated on the smallest possible number of 
components. By plotting the first PLS components, one can view main 
associations between X variables and Y variables. 
1.2.2.2. Applications of NIR spectroscopy in powder blending  
Owing to the multitude of advantages associated with NIR spectroscopy, its 
use to replace the traditional powder blend monitoring procedures/techniques 
has become an apparent solution in the pharmaceutical industry. A number of 
studies have been carried out to demonstrate the utility of NIR spectroscopy 
for powder blending process monitoring and control. Potential of NIR 
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 spectroscopy in powder blend analysis has been summarized by various 
researchers (Wargo and Drennen, 1996; Reich, 2005; Roggo et al., 2007). 
Since most drugs and excipients absorb NIR radiation, NIR measurements can 
provide homogeneity information regarding all mixture components. 
Moreover, the multi-sensing property of NIR spectra, resulting from 
absorption and scattering, provides information on both chemical and physical 
properties of the sample.  
Emergence of fiber optic reflectance probes enabled the non-invasive 
monitoring of powder blending with minimal assay time and sampling error. 
Sekulic et al. (1996) were among the first few groups who reported the use of 
a NIR fiber optic probe inserted in the axis of rotation of a tumble blender for 
real time on-line stop-start measurements at different times of the blending 
process. In another work, Sekulic et al. (1998) have used a fibre optic 
reflectance probe for qualitative evaluation of different blends in a small 
Flobin blender. Different mathematical pre-processings have been performed 
and assessed. 
NIR spectroscopy techniques for powder blend uniformity analysis have been 
used and reported by several authors for off-line analysis of blend samples 
taken from different blender locations at various blending times (Ciurczak, 
1991; Sanchez, 1995b; Wargo and Drennen, 1996), and on-line or in-line 
monitoring of powder mixing (Hailey et al., 1996; Sekulic, 1996; Sekulic, 
1998; Ufret and Morris, 2001; Duong, 2003). “Stop-start” and “dynamic” 
approaches of spectral data acquisition have been used for on-line and in-line 
monitoring. In a “stop-start” fashion, the blender was kept stationary, and in a 
“dynamic” fashion, the blender was rotating and powder bulk was constantly 
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 moving during NIR measurements. Berntsson et al. (2002) demonstrated that 
by high speed sampling, both average content and distribution of the mixture 
content can be been assessed in-line in a Nauta mixer, both at the laboratory 
and the production scale. The effect of sample movement on the spectral 
response was investigated by Berntsson et al. (2001). In their investigation, 
they showed that sample movement often caused unwanted spectral artefacts 
when heterogeneous samples were analyzed with a dispersive, mechanically 
scanning grating spectrometer. For the analysis of powders moving at 
moderate speeds, a fourier transform spectrometer was found to be suitable 
(up to 1 ms-1). El-Hagrasy (2001) pointed out that when using the stop-start 
fashion spectral acquisition, multiple spectral sampling points in the blender 
are required for accurate and precise estimation of blend end points. This was 
further confirmed by the use of a NIR camera that enabled large spectral 
images of the blend to be obtained.  
A number of data processing strategies for the assessment of blend 
homogeneity and/or optimal blending times from NIR measurements have 
been evaluated in the literature. Most of these reports were concerned with 
qualitative assessments, such as dissimilarity between the spectra of a mixture 
and the ideal spectrum of the mixture (Sanchez, 1995b; Maesschalck, 1998) or 
a moving block standard deviation of NIR spectra (Sanchez, 1995a; Sekulic, 
1998). Although these approaches generally revealed acceptable results, 
Wargo and Drennen (1996) suggested that bootstrap techniques provided a 
greater sensitivity for blend homogeneity assessment than chi-square 
calculations. Cho et al. (1997) have investigated the effective mass sampled by 
NIR fibre optic reflectance probes in blending processes to check whether the 
24 
 
 sampled mass meets the requirements of FDA regulations. Some recent papers 
(Berntsson, 2002) are also concerned with quantitative analysis, pointing out 
that quantitative analysis is a prerequisite for a complete resolution of the 
chemical and physical properties of the mixture. Non-linearity, which was 
found to be a feature of powder blends containing coarse and fine particles, 
was not a problem when using a cubic PLS calibration. Popo et al. (2002) used 
NIR spectroscopy to quantify the drug content in a blend from the spectra of 
the blend obtained by stream-sampling. Skibsted et al. (2006; 2007) developed 
a qualitative and a quantitative method to monitor the homogeneity of the 
blend. In another study, they demonstrated NIR spectroscopy applications for 
a complete manufacturing process in order to allow real-time release of 
products.  
1.2.2.3. Applications of NIR spectroscopy in tabletting 
Most of the literature published on applications of NIR spectroscopy for intact 
dosage form analyses mainly focused on tablets. The analyses carried out 
using NIR spectroscopy covered identification, assay and assessments of 
physical and biopharmaceutical parameters, such as hardness, coating 
thickness and dissolution rate.  
Quantitative NIR spectroscopic analysis of active ingredients/drugs in tablets 
has been extensively studied and reviewed in the literature. However, in the 
most primitive NIR spectroscopic assays, the active ingredients were either 
extracted from the tablets or the tablets were at least crushed to powder form 
prior to NIR measurements. Thus, tablets were not analyzed in intact forms.  
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 One of the most exploited area of NIR spectroscopy is fast and non-destructive 
identification of drugs and excipients in intact tablets, even through the blister 
packaging (Aldridge et al., 1994; Sondermann and Kovar, 1999). 
Development and subsequent commercialization of appropriate sample 
holders in the late 1980s paved the way for accurate measurement of active 
contents in intact tablets. These developments allowed a proper fit of even 
curved tablets, thereby reducing variable sample/tablet positioning (Candolfi 
et al., 1997) and stray light effects.  
In the last 10 years, a number of papers and reports had been published in the 
area of quantitative NIR measurements of active ingredients in intact tablets 
(Blanco, 1996; Buchanan et al., 1996; Gottfries et al., 1996; Molt et al., 1996; 
Eustaquio, 1998; Merckle and Kovar, 1998; Blanco, 1999; Corti et al., 1999; 
Trafford et al., 1999; Blanco, 2000; Moffat, 2000; Chen et al., 2001; Thosar et 
al., 2001; Li et al., 2003). These papers have addressed many aspects for 
successful implementation of NIR spectroscopy. The rationale for selecting 
the appropriate measurement mode, and the practical and regulatory aspects to 
be considered in choosing the appropriate chemometric approach, including 
calibration sample selection and data pre-processings, were among the most 
discussed and studied aspects in these papers.  
Selection of the measuring mode for NIR spectroscopic tablet analysis 
strongly depends on tablet thickness, composition and target parameter. Li et 
al. (2003) reported that the reflectance mode mainly used in the early works, 
may have some limitations since it covered only a certain part of the tablet. 
This could be detrimental, particularly in the case of multilayer tablets where 
homogeneity within the tablet cannot be assured or is part of the delivery 
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 concept. Similarly, in the case of coated tablets, use of appropriate mode 
would be of great importance, as spectral information could be altered by the 
composition of the coating polymer. On the other hand, there are certain 
situations where spectra are acquired in dynamic manner and use of 
reflectance mode is recommended as it results in an analysis with enhanced 
accuracy because of the reduced sampling errors associated with moving 
tablets (Cogdill et al., 2005). After adopting the transmittance measurements, 
some authors reported improved performances of MVC models in terms of 
accuracy, precision, and sensitivity for various tablet assays (Gottfries, 1996; 
Thosar, 2001). The improved performance was attributed to the scanning of 
the larger volume of the tablet matrix. However, the adoption of transmittance 
measurements is confined by the significantly narrower wavelength range 
available in “diffuse” transmittance mode, and thus limited its application to 
very thick tablets (Dempster, 1992). In view of these paradoxical situations, 
regulators have expressed their concerns regarding measurement modes for 
content uniformity testing. In recent publications concerning NIR 
spectroscopy for content uniformity analysis, it was suggested that selection of 
the appropriate measuring mode is very subjective and should be carefully 
decided considering processing and formulation parameters (Blanco, 1996; 
Buchanan, 1996; Gottfries, 1996; Molt, 1996; Eustaquio, 1998; Merckle and 
Kovar, 1998; Blanco, 1999; Corti, 1999; Trafford, 1999; Blanco, 2000; 
Moffat, 2000; Chen, 2001; Thosar, 2001; Li, 2003).  
Drennen and Lodder (1990) reported application of NIR spectroscopy for 
monitoring the hydrolysis of acetylsalicylic acid to salicylic acid in tablets 
upon water absorption. The authors predicted the contents of water and 
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 salicylic acid from a single measurement as the spectral information 
constituted both the parameters. NIR spectroscopy was also used for studying 
the polymorphic transitions in tablets (Reich, 2000-a).  
NIR spectroscopy has also shown to be suitable for fast and non-destructive 
estimation of mechanical properties of tablets such as hardness measurements 
and additional information on structural features of the tablets. Application of 
NIR spectroscopy for tablet hardness testing has been reported by several 
authors (Kirsch and Drennen, 1995; Morisseau and Rhodes, 1997; Ebube et 
al., 1999; Kirsch and Drennen, 1999; Chen, 2001). The first study describing 
the application of NIR diffuse reflectance spectroscopy to determine tablet 
hardness was reported by Drennen and co-workers (Kirsch and Drennen, 
1995; Kirsch and Drennen, 1999). Kirsch and Drennen (1995) investigated 
different formulations including coated tablets at hardness levels ranging from 
1 to 7 KPa and from 6 to 12 KPa.  
Morisseau and Rhodes (1997) studied a matrix of MCC and magnesium 
stearate compressed at six hardness levels ranging between 2 and 12 kg and 
found out that SEP values were in the same range (0.3-0.6 kg) for two 
different tablet formulations of hydrochlorothiazide (15 and 20% w/w) and 
chlorpheniramine (2 and 6% w/w). The MLR and PLS regression techniques 
were used to model the diffuse reflectance spectra obtained from these tablets. 
Use of artificial neural networks (ANN) to predict tablet hardness from diffuse 
reflectance NIR spectral data was reported by Chen et al. (2001).  
The use of NIR transmittance mode for determination of tablet hardness for 
the first time was reported by Reich (2000-a). The author reported that use of 
transmittance spectra gave a better predictability of whole tablet hardness than 
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 reflectance measurements. He attributed the findings to the fact that 
compaction of pharmaceutical powders results in density variations in 
different directions and regions of the tablet (Nyström, 1993), (Reich, 2000-a).  
Application of NIR spectroscopy to predict drug dissolution rates from whole 
tablets was reported for the first time by Zaninikos et al. (1991).  They 
reported the prediction of the dissolution rate of carbamazepine tablets 
following exposure to high humidity. NIR spectra of tablets with a rate-
controlling film coat were used by some authors to correlate the drug 
dissolution profile of a whole tablet (Kirsch and Drennen, 1995; Frickel, 1998; 
Frickel, 1999; Reich, 2000; Frickel, 2000; Reich, 2000-b; 2001b). Kirsch and 
Drennen (1995) predicted the dissolution profile of theophylline tablets coated 
with various amounts of ethyl cellulose based on NIR diffuse reflectance 
spectra of the tablets.  
Prediction of film coat thickness of tablets and pellets was also carried out by 
some researchers. Both NIR diffuse reflectance and transmission spectroscopy 
was used to predict film coat thickness (Kirsch and Drennen, 1995; Frickel, 
1998), and even film coat uniformity (Frickel, 1999; Reich, 2000; Frickel, 
2000) of tablets.  
1.3. Research gaps 
1.3.1. Surface roughness of excipients particles in ordered mixing 
The effect of surface roughness of excipient particles on ordered mixing and 
dosage form performance has been explored by many researchers with various 
commercial carrier particles (Kawashima et al., 1998; Podczeck, 1998 and 
Flament, 2004) and surface-modified lactose particles prepared by submersion 
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 treatment with aqueous alcoholic solutions (Zeng et al., 2001; Dickhoff, 
2006), re-crystallization at various controlled conditions (Zeng et al., 2000; 
Zeng et al., 2000-b; Zeng et al., 2001; El-Sabawi, 2006), high shear mixing 
(Young et al., 2002; Ferrari et al., 2004), spray-drying (Gilani et al., 2004; 
Chidavaenzi et al., 2001) and precision coating (Chan et al., 2003). Most of 
these studies were mainly carried out for dry powder inhalational 
formulations. Nonetheless, comparisons made between commercially 
available particles (e.g. lactose, mannitol) may not be able to accurately reflect 
the effect of surface roughness of excipient particles fully as other factors 
might contribute to the effect observed and these include differences in the 
degree of crystallinity or shape of the carrier particles or material types used. 
The reported submersion treatment and re-crystallization investigations 
utilized small static laboratory scale techniques and were likely to produce 
powders with inter-batch variations. On the other hand, high energy build up 
and changes in particle size during high shear mixing may not be favorable as 
particles are prone to fracture along with the changes in surface roughness. 
Spray dried carrier particles are often amorphous or comprise a mix of 
different crystal forms. Furthermore, stability of the amorphous particles is 
also a concern. In contrast, precision coating as a method for lactose surface 
modification has advantages of being able to be conducted in a dynamic 
manner. Controlled airflow in the precision coating zone can prevent the 
agglomeration of small particles in the presence of the spray liquid (Chan et 
al., 2003), allowing each particle to be treated individually. Precision coating 
has the ability to round off protrusions or asperities present on the surface of 
the lactose particles without altering other fundamental physical properties 
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 such as size, shape and crystallinity. Furthermore, precision coating is a 
scalable process that could be employed in large scale production. Hence, it 
will be of an added advantage to utilize precision coating techniques for 
surface modification of lactose particles.   
On the other hand, abundant literature has been published on roughness 
measurement techniques for pharmaceutical particles and compacts. 
Profilometry (Podczeck, 1998) and scanning probe microscopy (SPM) (Li et 
al., 1998; Heng et al., 2000) are routine techniques used in material science 
and the pharmaceutical industry to quantify the surface roughness of materials 
and excipients respectively. 
Li and Park (1998) determined surface roughness by SPM and analyzed the 
roughness measurement using fractal analysis. Heng et al. (2000) also 
employed SPM to quantifying the surface roughness of lactose carriers with 
height parameters such as average roughness (Ra), 10-point mean roughness 
(Rz) and maximum peak to valley height (Ry). Despite their frequent use, 
these traditional methods are associated with a number of drawbacks: contact 
mode profilers and scanning probe microscope are prone to damage the test 
surface resulting in false surface measurements, slow speed and restricted area 
of measurements because of limited movement of the cantilever no matter 
whether it is in the contact or non-contact mode.  
Other alternative methods have been used by researchers to quantify surface 
roughness, for example, Kawashima et al. (1998) used the specific surface 
areas (SSA) of carriers determined by air permeametry and Brunauer, Emmett 
and Teller (BET) adsorption methods as the estimation of surface roughness. 
However, this method has its own limitations because SSA is an indirect 
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 measure of surface property and may be influenced by other physical 
properties associated with bulk powder. 
A non-contact optical interferometer based on the principle of two-beam 
optical interferometry has been widely used in the field of material science for 
surface characterization because of its fast speed of measurement and high 
resolution (Wyko). Surface roughness can be measured at high resolution and 
resulting three dimensional (3D) profiles could be used to quantify surface 
roughness using different parameters. Hence, both qualitative and quantitative 
estimation of surface roughness is possible with a high level of accuracy using 
the optical interferometer. In the pharmaceutical field, the optical 
interferometer has been used to study the surface roughness of tablets and 
pellets but there are very few studies which actually investigated its utility for 
surface characterization of fine coarse excipients particles. Hence, there is a 
need to investigate the utility of optical interferometer for surface 
characterization of excipients. 
1.3.2. NIR spectroscopy for in-line monitoring of drug and 
excipients in tablet manufacturing process 
Most of the earlier studies carried out using NIR spectroscopy in the powder 
blending field were aimed at quantifying the active component in binary or 
multi-component blends and at determining blend uniformity end point based 
on the distribution of an active component within the powder bed (Hailey, 
1996; Wargo and Drennen, 1996; Sekulic, 1998; Patel et al., 2000; Ufret and 
Morris, 2001; Berntsson, 2002; Sulub, 2009). However, some of the recent 
works (Li and Worosila, 2005; Benedetti, 2007; Abatzoglou et al., 2008; 
Lapointe-Garant et al., 2008; Shi, 2008; Wu, 2009) carried out in this field 
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 have helped in improving our understanding of the powder blending process. 
Abtzoglou et al. (2008) and Lapointe-Garant et al. (2008) studied the in-line 
application of NIR spectroscopy for real-time monitoring of a pharmaceutical 
blending process through multivariate analysis-derived models. Abtzoglou et 
al. (2008) studied the blend flow velocity and drug level effect on 
homogeneity and NIR spectroscopy measurements in a 30-L V blender. 
Benedetti et al. (2007) successfully developed an in-line NIR technique for 
quantifying the composition of flowing multi-component dense powder 
mixtures.  Li et al. (2005) and Wu et al. (2009) investigated the ability of NIR 
spectroscopy to quantitatively predict the individual blend components in 
multi-component blends. Wu et al. used the combination approach of NIR 
spectroscopy and UV spectroscopy to quantify ibuprofen, microcrystalline 
cellulose (MCC), Eudragit and hydroxypropyl methyl cellulose in powder 
blends using a laboratory scale turbula mixer.  However, in both the studies, 
the blender was stopped during blending and a NIR probe was inserted into 
the powder bed for spectral acquisition. Thus, the possibility of disturbing the 
powder bed was not eliminated. Moreover, off-line measurements employed 
were unlikely to represent the actual state of moving powder. Simultaneous in-
line quantification of drug and excipients in cohesive powder blends in a bin 
blender using NIR has been reported by Shi et al. (2008) in which the 
characterization of the ternary powder blend based on two NIR sensors fixed 
in the bin blender was carried out. However, the blending study undertaken 






NIR spectroscopy is being extensively used in the pharmaceutical industry to 
determine drug content uniformity of tablets (Blanco et al. 2002; Blanco and 
Alcala, 2006). However, in-/on-line quantification studies of drug in tablet 
dosage forms using NIR are relatively limited (Colon et al., 2005). There had 
been relatively less emphasis on quantification and tracking distribution of 
drug and excipients simultaneously in real time. Cournoyer et al. (2008) 
characterized tablets for multiple components but the analysis was carried out 
on a limited number of tablets and by a static measurement mode. Therefore it 
becomes imperative to investigate the applicability of in-line NIR sensor 
(dynamic sampling mode) for quantifying the contents of drug and 
excipients simultaneously in tablets and to monitor the tabletting process in 











 2. HYPOTHESES AND OBJECTIVES 
2.1. Hypotheses  
 
There is a growing concern regarding blend homogeneity attainment and its 
accurate determination with the introduction of a number of low dose drugs 
which, more often than not, need to be micronized for their ease of 
formulation into a dosage form such as capsules, tablets, dry powder inhalers. 
However, the use of micronized drug particles makes it difficult to achieve 
uniform mixing with the inert ingredients, owing to their micron size range 
and poor flow properties. For such situations, ordered mixing (Hersey, 1975), 
which involves the adhesion of micronized drug particles onto the surface of 
coarse carrier particles, is normally preferred. As this is a surface 
phenomenon, surface roughness of the carrier particles is of utmost 
importance in determining the extent to which drug particles adhere to or 
detach from the carrier surfaces. It was therefore hypothesized that the surface 
roughness of coarse particles would affect the uniformity and physical stability 
of low dose blends.   
Another aspect of concern in traditional manufacturing process of solid dosage 
forms is the assessment of quality of finished drug products and their 
intermediates. Firstly, these quality assessments are generally based on tests 
conducted on a limited number of samples/tablets. However, the samples 
obtained are rarely representative of the production batch (30-40 samples 
weighing to unit dose from approximately 100 kg of blend and 20-30 tablets 
from approximately millions of tablets). Secondly, in the quest to achieve drug 
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 content uniformity, the analyses of excipients, which perform equally 
important roles in ensuring the technological and bio-pharmaceutical 
performance of the final dosage form, have been neglected. Thirdly, 
particularly in the case of powder blending, the method of acquisition of 
necessary data for evaluating the distribution of blend components usually 
involves destructive sampling techniques violating Allen’s 2 “golden rules” 
(Lantz and Schwartz, 1981) of powder sampling which states that a powder 
should always be sampled when in motion, and that sampling should be done 
in small increments of time. Therefore, it was hypothesized that with the 
application of NIR spectroscopy and multivariate data analysis, in line 
monitoring of the low dose tablet manufacturing process especially for 
distribution of drug and excipients is possible. Furthermore, with the usage of 
NIR spectroscopy the drawbacks associated with traditional quality 
assessment measures can be avoided. Thus, real time information of the 
conventional solid dosage form manufacturing processes and transformation 
of such shielded processes to make them more visible and better understood 
would be possible. 
2.2. Objectives 
To test the above mentioned hypotheses, the work for this PhD project was 
carried out with the following objectives: 
Study I: To demonstrate the utility of optical interferometry for qualitative 
and quantitative surface characterization of lactose particles. In this study, the 
novel optical interferometry method was assessed and compared with the 
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 traditional scanning probe microscopy for the surface characterization of 
lactose particles. 
Study II: To investigate the influence of surface roughness of coarse lactose 
particles on bulk flow and extent of adhesion of micronized drug particles and 
thus to study the possible correlation between particulate and bulk properties. 
In this study, coarse carrier particles with different surface roughness were 
prepared using precision coating process.  The surface roughness of lactose 
particles was related to their flow properties and capacity to retain drug 
particles when in bulk powder form.  
Study III: To investigate the applicability of in-line NIR sensor and different 
technical issues during establishment of the process analytical technique for 
quantifying the drug and excipient contents simultaneously during the tablet 
manufacturing process.  
Study III-A: To illustrate the issue of calibration sampling paradox in 
NIR spectroscopy using multi-component powder blend.  
This work reported an effort to illustrate the issue of sampling paradox 
in NIR spectroscopy MVC models with reference to the multi-
component dry powder blend. A D-optimal mixture design was used to 
impart the maximum possible variability in calibration samples and 
spectral acquisition was carried out using three different strategies, (a) 
simulated physical mixtures prepared in the laboratory with spectral 
acquisition carried out in a static manner, (b) calibration samples 
blended in an intermediate bulk container (IBC) bin blender and 
spectral acquisition carried out in a static manner, and (c) calibration 
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 samples blended in an IBC bin blender and spectral acquisition carried 
out in a dynamic manner. 
Study III-B: To illustrate the suitability of an alternative approach for 
generating robust and sensitive MVC models. To investigate the 
mixing of a cohesive multi-component powder blend consisting of 
micronized drug in an IBC bin blender with in-line NIR sensor and to 
gain insights into the effect of premixing and use of prism attached at a 
predefined position within the IBC on the mixing performance of 
individual blend components. 
Study III-C: To investigate the utility of NIR spectroscopy for real 
time monitoring of tabletting unit operation in a low dose multi-
component tablet manufacturing process. 
The aim of the tabletting study was to investigate applicability of an in-
line NIR sensor for quantifying the contents of drug and excipients 
simultaneously and to track possible segregation during tabletting. The 
NIR spectra was obtained in the reflectance mode since this mode was 
reported to give results with enhanced accuracy because of the reduced 
sampling errors associated with moving tablets (Cogdill et al., 2005). 
Another growing concern for NIR non-destructive technique 
implementation is the likelihood of obtaining prediction results with 
errors almost equivalent to the traditional HPLC or UV methods. An 
attempt was made in the proposed study to address this concern by 
developing the MVC models which include maximum possible 
variability encountered during actual tabletting unit operation and 





content uniformity analysis of drug and excipients was carried out to 










 3. EXPERIMENTAL 
3.1. Study I: Optimization of optical interferometer for surface 
roughness characterization 
3.1.1. Materials  
Four different grades of lactose powders, Pharmatose 200M, Pharmatose DCL 
40 (DMV International, The Netherlands), Inhalac 230 and Capsulac S 
(Meggle GmbH, Germany) were used in this study. The lactose grades were 
jet-sieved (Micron Air Jet Sieve, Hosokawa Micron, USA) under vacuum 
pressure of 20–25 cm water for 2 min to obtain particles within the 63-125 μm 
size fraction. The sieved samples were stored in airtight desiccators under 
controlled environment conditions of 25 °C and relative humidity of 50%. 
Pharmatose 200M and Pharmatose DCL 40 would be referred to as 200M and 
DCL 40 hereinafter. 
3.1.2. Methods 
3.1.2.1. Scanning Probe Microscopy (SPM) 
Lactose particles were first sprinkled onto a double-side adhesive tape (Scotch 
3M, USA) mounted on a sample holder. A silicon nitride probe cantilever 
(Pointprobe sensor type NCHR-20, Nanoworld AG, Switzerland) was 
employed under non-contact mode in a scanning probe microscope (SPM-
9500, Shimadzu, Japan). Surface roughness of different grades of lactose 
particles was determined at scan size of 15 μm x 15 μm, and at a scan rate of 1 
Hz. Thirty particles were randomly selected and scanned for each lactose 
grade. Roughness parameters evaluated were mainly amplitude parameters 
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 determined solely by the peak heights or valley depths (or both) of profile 
deviations, irrespective of their spacing along the surface.  
Arithmetic mean roughness (Ra) is the arithmetic mean value of the 
departure of the roughness profile over a measured distance, above and below 
a central reference line that divides the roughness curve into two equal parts. It 





= ∫           
where L is the reference length, and f(x) is the height relative to the reference 
line. A higher Ra value is associated with greater surface roughness. 
Fractal dimension (FD) is a statistical quantity that gives an indication of 
how completely a fractal appears to fill spaces or irregularities on the surface. 
This analysis uses the algorithm which fills the surface profile curves using 
cubes of different sizes. Size and number of cubes required to fill the surface 
profile are critical determinant of fractal dimension. Cell size and number of 
data points can be obtained from the algorithm. For a fractal structure surface, 
fractal dimension is the negative slope of the straight line obtained by fitting 
the data points. Usually FD values range from 2 to 3. D ≈ 2 refers to the 
classical assumption of smooth and flat areas of the particle surface. 
Surface ratio (SR), i.e. the ratio of calculated surface area and scan size. For 
this analysis, sampling points in a specified area of a particle were used to 
make a 3D mesh, and each lattice was then divided into triangles to add areas. 
Materials with rougher surfaces, exhibit higher SR values and vice versa. 
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 Statistical analyses were carried out using one-way ANOVA (Analysis of 
variance between groups) at p-value of 0.05 (SPSS, version 11.0.0, SPSS Inc., 
USA). 
3.1.2.2. Optical interferometry 
Particle surface roughness was determined using an optical interferometer 
(Wyko NT1100, Veeco, USA) (Figure 2). A glass slide was used as the 
substrate to mount the lactose particles. The magnification of 42.9X and the 
scan size of 109 x 144 µm were obtained by the combination of 20X objective 
lens and 2X field of view lens. This magnification gave lateral resolution of 
195.85 nm and a vertical resolution of down to 1 Å. Mounted particles were 
scanned and corresponding surface images were captured. Roughness 
parameters were determined from the analysis of captured images using 
computer software (Vision 3.0, Veeco, USA).  At least 100 particles from each 
lactose grade were scanned and a sub-defined region of 30 µm x 30 µm was 
used for actual surface analysis.  
For quantitative surface analysis, amplitude parameters determined by the 
peak heights or valley depths (or both) of profile deviations were used to 
differentiate the surface roughness of the lactose particles. 
Arithmetic mean roughness (Ra) is the mean of the absolute values of the 
surface departures from the mean plane and calculated as:  
         
where M and N are the number of data points in the X and Y directions of the 
array, and Z is the surface height relative to the reference mean plane.  
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 Root mean square roughness (Rq) is calculated by squaring each height 
value in the dataset, then taking the square root of the mean as given in the 
equation:  
       
Rq value is more sensitive to peaks and valleys as it represents the standard 
deviation of the surface heights.  
Ratio of Rq/Ra, a measure of surface variability, was also used to determine 
the repeatability of surface appearances. This ratio will be close to 1 if the 
surface profile exhibits regular occurrences of heights and peaks whereas 
irregular occurrence of peaks and valleys result in a large ratio as Rq values 
are weighted higher than Ra.  
 
 
Figure 2: Wyko NT1100 optical interferometer.  
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 3.2. Study II: Surface modification of lactose particles 
3.2.1. Materials 
Chlorpheniramine maleate coarse powder was obtained from Merck, 
Singapore. Commercially available α-lactose monohydrate powders, 
Pharmatose 100M, Pharmatose 450M (DMV, International, The Netherlands) 
and Inhalac 230 (Meggle, GmBh, Germany) were used. 
3.2.2. Methods  
3.2.2.1. Processing of raw materials 
Micronized lactose (mean size 2 µm) and lactose fines (mean size 15 µm) 
were obtained by milling  Pharmatose 100M in a fluidized-bed opposed jet 
mill (Hosakawa, AFG 100, Germany) at a pressure of 0.5 MPa and classifying 
speed of 18000 rpm and 4000 rpm respectively. Chlorpheniramine coarse 
powder was micronized to produce micronized chlorpheniramine (µCPM; 
mean size 3 µm) particles by jet milling at a pressure of 0.4 MPa with a 
classifying speed of 18000 rpm. 
3.2.2.2. Surface modification of lactose particles using precision coating 
Surface modifications of Inhalac 230 particles were carried out by spraying 
atomized droplets of 40 % v/v iso-propyl alcohol (IPA)-water mixture or 
dispersion of micronized lactose particles onto 1 kg of fluidized feed material 
in a precision coater (Figure 3) (MP1, GEA Pharma Systems, UK). 
Experimental details could be found in Table 1. Operating conditions for the 
coating process were: 2 bar atomizing air pressure, 55 m3/h fluidizing air flow 
rate, 60°C inlet air temperature and 3 g/min spray rate. After completion of the 
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 coating process, the surface modified powders were fluidized for another 30 
min  at 70°C followed by collection and oven drying at 60°C  for another 3 h 
to ensure complete drying. Inhalac 230, Inhalac-smoother, Inhalac-rougher 
and Inhalac-roughest would be referred to as INH-C, INH-S, INH-R and INH-
RR hereinafter.  
 




 Table 1: Feed materials and spray liquids used to prepare INH-S, INH-RR, 
INH-R 
 
Lactose grade Feed material (1kg) Spray liquid 
INH-S Inhalac 230 
40% v/v IPA-water 
mixture 
INH-RR Inhalac 230 +  lactose fines*  
40% v/v IPA-water 
mixture 
INH-R Inhalac 230 
Micronized lactose 
dispersed in saturated 40% 
v/v IPA/water mixture**  
 
*A mixture of 300 g of lactose fines (mean size 15 μm) and 700 g of Inhalac 
230 was used as feed material.**The saturated solution of lactose was 
prepared by introducing excess of Pharmatose 450M into 40% v/v IPA-water 
mixture and stirring overnight with a magnetic stirrer in a stoppered 
volumetric flask. The dispersion was then filtered through a sintered glass 
filter with pore size of 0.45 µm to remove excess Pharmatose 450M. 
Micronized lactose powder (mean size 2 µm) 4% w/w was then added to this 
saturated solution and used immediately to spray onto the lactose particles 
during the precision coating process. 
 
3.2.2.3. Size classification 
Lactose powders were sieved to obtain the 75-100 μm size fraction, using an 
air jet sieve (Hosokawa Micron, USA) under vacuum pressure of 15 mmHg. 
Sieved samples were then equilibrated at 25°C and 50 % relative humidity for 
at least 72 h prior to use. 
3.2.2.4. Differential scanning calorimetry (DSC) 
DSC (DSC-50, Shimadzu, Japan) was conducted to assess the crystallinity of 
the lactose particles. Lactose samples (4 to 7 mg) were heated from 20 to 
300°C in an sealed aluminum pan. The heating rate was set at 5°C/min. 
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 Thermograms were analyzed by computer software (Ta60 1.40, Shimadzu, 
Japan). 
3.2.2.5. Shape analysis 
An approximate amount of sieved lactose particles from each grade was 
mounted in liquid paraffin and observed under a light microscope (BX61, 
Olympus, Japan).  Images were captured using a video camera (DXC-390, 
Sony, Japan) and analyzed by computer software (Image Pro Plus 6.3, Media 
Cybernetics, USA) to obtain the aspect ratio and roundness values.  Images of 
at least 130 particles for each lactose grade were used. The equations used to 
calculate aspect ratio and roundness are as follows: 
            
        
  
where P is perimeter, A is area, Hmax and Vmax are the maximum horizontal 
and vertical distances of the projected image of the particle, respectively. 
3.2.2.6. Assessment of surface roughness 
 Specific surface area measurement (SSA) 
Specific surface area of the lactose particles was measured by Brunauer, 
Emmett and Teller method (SA 3100, Beckman Coulter, USA) using nitrogen 
as the adsorbate gas. Before each measurement, samples were degassed under 
vacuum for 24 h at 60°C. 
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  Scanning electron microscopy (SEM) 
Qualitative assesment of surface roughness of lactose particles was carried out 
using a scanning electron microscope. After gold sputter coating (JFC-1100, 
JEOL Ltd., Japan) under vacuum, lactose particles were examined under a 
scanning electron microscope (Phenom, FEI Company, USA) and 
photomicrographs of the particles obtained. 
 Optical interferometry 
The procedure used was as described in section 3.1.2.2. 
3.2.2.7. Assessment of flow properties 
 Dynamic flow characterization using avalanche flow tester 
Avalanche flow measurements (Aero-Flow powder tester, 3250, TSI, Inc., 
USA) were carried out for the lactose grades. A sample quantity equivalent to 
50 mL bulk volume was loaded into a cylindrical perspex container and 
sealed. The filled disc was then mounted onto the rotating shaft and the light 
cradle was aligned vertically. The disc was rotated at 7 different speeds 110, 
130, 150, 170, 190, 210 and 230 s/rev for 10 min. Resultant strange attractor 
plots were used to determine the mean time to avalanche (MTA) and scatter 
values.  
The basic principle behind the flow measurement using avalanche flow can be 
explained as follows: With rotation of the disc, the test powder builds up to an 
unstable position from which it avalanches and cascades to create a new stable 
surface. Detection and measurement of the avalanches is assessed by the 
degree of obliteration of the light source shone onto an array of photocells 
48 
 
 behind the filled disc. A voltage is generated by the photocells, depending on 
the amount of light falling on the cells, which in turn is dependent on the area 
of the photocells shielded from the light source by the powder heap. The time 
taken for the consecutive avalanches is recorded as T1, T2, T3 and so forth. 
The data is presented in the form of a discrete phase space map known as a 
strange attractor plot. The first data point is created using T1 and T2 as the x- 
(Tn) and y- (Tn+1) coordinates, respectively. The second data point is created 
using T2 and T3. All the data points within the specified test duration are 
joined together to complete the strange attractor plot. The center of this plot is 
represented by the mean time to avalanche (MTA), which refers to the average 
time required for a complete avalanche. The spread of points around the center 
is denoted by the scatter and it refers to the standard deviation between the 
times to avalanche.  
Avalanche flow (AFI) and cohesive interaction indices (CoI) were then 
subsequently calculated (Soh et al., 2006). 
AFI= 1/m          
where m is the slope of the graph for MTA against drum speed. A larger AFI 
value is indicative of better flow and vice versa. 
CoI= n          
where n is the slope of the graph for scatter against drum speed. A larger CoI 
value is indicative of higher cohesiveness. 
 Determination of angle of repose 
Angle of repose was determined using the powder tester (Powder Tester, 
Hosokawa Micron, Japan). Appropriate amount of powder was passed through 
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 a 180 μm aperture size sieve onto the glass funnel that was vibrated at 
amplitude of 1 mm to form a powder heap on the cylindrical stainless steel 
stand positioned underneath it. The angle of repose was defined as the angle 
formed between the side of the heap and the horizontal plane. Four replicated 
runs were carried out for angles of repose and the results were averaged.  
 Compressibility studies 
Bulk (ρb) and tapped (ρt) densities were obtained using a tapping apparatus 
(Stampfvolumeter, JEL, Germany). A measuring cylinder exactly cut to 50 
cm3 was filled till overflowing with the powder, then excess removed and the 
weight of powder determined.  Thus, ρb was determined as the quotient of the 
weight of powder to cylinder volume. Filled cylinder was subjected to steps of 
2500 taps till no further change in the final tapped powder volume was 
obtained. ρt was calculated as the quotient of powder weight  to the final 
tapped volume occupied. The Carr index (CI) and Hausner ratio (HR) were 










ρ=         
Experiments were carried out in triplicates and results were averaged. 
3.2.2.8. Powder bed porosity 
True density (ρtrue) of the lactose grades was determined using a helium 
pycnometer (Penta-pycnometer, Quantachrome, USA). The powder samples 
were pre-dried for 3 h in a convection oven at 60°C and kept overnight in 
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 desiccators before use. Small sample cells were filled to 90 % fill with lactose 
powder and purged with helium gas for 10 min before determinations. 
Porosities of the lactose powder beds were calculated from true density (ρtrue) 
and bulk density (ρb) as follows: 
 
3.2.2.9. Blending of µCPM and lactose carrier particles 
Binary mixtures of 4 % w/w μCPM and each of the lactose grades were 
prepared in a batch size of 50 g. The samples were premixed using a vortex 
mixer (VX9/VXR, Ika, Germany) for 5 min. Each mixture was then passed 
through a 355 µm aperture size sieve to break up large agglomerates, followed 
by further mixing for another 15 min. Uniformity of the mixture was evaluated 
by taking random samples from the bottles (approximately 250 mg). Samples 
were then evaluated using UV spectroscopy at 262 nm for μCPM content. 
Mixtures with the percentage relative standard deviations (% RSD) below 6 % 
were considered as uniformly mixed. 
3.2.2.10. Assessment of surface roughness for retaining µCPM particles 
Uniformly mixed binary blends of μCPM and each of the lactose grades were 
subjected to vibration on a mechanical sieve shaker (VS 1000, Retsch, 
Germany) for 5 and 10 min at amplitude of 1 mm. A sieve with 63 µm 
aperture size was used to allow the passage of 3 µm μCPM particles upon 
vibration. After vibration cycles, the powder samples were analyzed using UV 
spectroscopy to determine the μCPM content retained. The vibration stress 
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 was employed to estimate the strength of inter-particle forces within the 
powder system (Saint-Lorant et al., 2007). Experiments were carried out in 
triplicates and results averaged. The percentage retained was used as an 
indicator of the capacity of the lactose grades to retain the μCPM on the 
particle surfaces and was calculated as follow: 






where Cprior and Cpost are the contents of μCPM in the powder mixture (% 





3.3. Study III:  In-line monitoring of tablet manufacturing 
process using NIR spectroscopy  
3.3.1. Materials 
Materials used in this study are given in Table 2. Prior to experimentation, all 
the materials were passed through a 355 μm aperture size sieve in order to 
break up any loose agglomerated lumps in the bulk powders, and stored for at 
least 48 h at 25°C and 50 % relative humidity.  
3.3.2. Methods 
3.3.2.1. Bin blender and NIR instrumentation 
The setup for spectral acquisition of blends is shown in Figure 4. An optical 
head comprising a sapphire window (30 mm) was mounted on the lid of the 
IBC blender (SP15, GEA Pharma Systems, UK) for NIR spectral acquisition. 
NIR spectral sensor used was MCS 611 NIR 2.2, (Carl Zeiss, Germany).  The 
setup allowed spectral acquisition of 980-2100 nm with 1 nm resolution. 
3.3.2.2. Rotary tablet press and NIR instrumentation  
The setup for spectral acquisition of tablets is shown in Figure 5. The fibre 
optic probe was positioned inside the metallic holder and mounted on the 
tabletting machine (Rimek, Karnavati, India) just adjacent to the tablet 
ejection area. Spectral sensor (MCS 611 NIR 2.2) and NIR diffuse reflectance 
measurement probe (QR600-7, Ocean Optics, USA) with a 3.18 mm diameter 
spot size were used for NIR spectral acquisition (980-1900 nm) of tablets. A 
clearance of 0.5 mm between the tablet and probe was always maintained to 
avoid errors associated with the sampling distance. 
 Table 2: Materials used for blending and tabletting studies 
 




Mean size (μm) Abbreviation Mean size (μm) Abbreviation Supplier 
Chlorpheniramine maleate 110 CPM 3 µCPM Merck, Singapore 
Pharmatose 100M 128 100M 140 100M 
DMV, The 
Netherlands 
Inhalac-230 110 NA NA NA Meggle, Germany 
Avicel PH102 130 MCC 143 MCC 
FMC Biopolymer, 
USA 




*For study III-B and III-C, Pharmatose 100M and Avicel PH102 narrow size fractions were obtained using nest of sieves, with 
aperture sizes of 90 and 180 µm, vibrated at 1 mm amplitude on a mechanical sieve shaker (VS 1000, Retsch, Germany). Particle 
size of the micronized drug (µCPM) was determined using optical microscopy. For coarse grade drug (CPM), lactose and MCC 
dry powder module of laser diffraction sizer was used for particle size analysis. For magnesium stearate, small volume (wet) 







Figure 4a: Experimental setup for the in-line quantification of drug and 
excipients during blending A: SP 15 IBC blender B: (1) IBC, (2) port for 
prism attachment (3) modified IBC lid with NIR sensor and (4) axis of 
rotation C: IBC with the lid open depicting the prism (horizontal bar 









Figure 4b: Schematic representation of A: Optical head (NIR sensor) of SP 15 








Figure 5: Experimental setup for the in-line quantification of drug and 
excipients during tabletting: (A) Rotary tablet press with NIR probe (B) 
hopper, (C) probe and (D) optical head showing 6 illumination fibers around 1 








3.3.2.3. NIR spectral acquisition and OLUP for in-line monitoring 
Raw energy spectra were obtained from the light signals from the optical head 
using the MCS 611 NIR 2.2 spectral sensor (Carl Zeiss, Germany)  and 
transferred using radio frequency to the microprocessor using the Aspect Plus 
(version 1.76, Carl Zeiss, Germany) and Process Explorer (version 1.1.0.6, 
Carl Zeiss, Germany) softwares. Unscrambler 9.8 (version 9.8, Camo Inc., 
India) was used off-line to build the MVC models. The MVC models for 
different blend components were then uploaded into the Process Explorer 
using the Online Unscrambler Predictor (OLUP) software. OLUP packaged 
Unscrambler MVC models into a dynamic link library (DLL, 32 bit only) 
protocol. Through these protocols, Process Explorer was interfaced with the 
OLUP for obtaining in-line quantification of each of the blend components. 
3.3.2.4. Chemometric data pre-processing  
Chemometric data pre-processing was performed using Unscrambler 9.8 
(version 9.8, Camo Inc., India). The spectra obtained were smoothed using 
moving average smoothing with segment size of 3 and pre-processed with 
standard normal variate (SNV) followed by 1st derivative employing 9 
smoothing points and 2nd polynomial order, unless otherwise stated.  Partial 
least square (PLS) regression method was then used to build the MVC models 
for each component. The calibration statistics used to decide on the 
performance of the models were the number of principal components (PC), X 
and Y explained variances; R2 and RMSECV obtained after leave one out full 
cross validation. Further details are given in the individual sections 
corresponding to the respective studies. 
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 3.3.2.5.  Calculation of reference values 
The reference values used for calibration samples were calculated 
gravimetrically, from the actual weights of the calibration mixtures (% 
Ingredient A=100 x weight of ingredient A/total weight of mixture). 
3.3.2.6. UV spectrophotometric method for determination of μCPM 
content 
Powder sample or each individual tablet was weighed and diluted to 200 mL 
with distilled water in a volumetric flask.  The flask was then shaken and 
ultra-sonicated for 10 min to ensure complete disintegration of the blend 
component or tablet. Approximately 20 mL aliquot per sample was subjected 
to centrifugation at 2000 rpm for 5 min and the resultant supernatant solution 
was analyzed for the concentration of μCPM using a UV spectrophotometer 
(UV-3101 PC, Shimadzu, Japan) at 262 nm. 
3.3.3. Study III-A: Calibration sampling paradox in powder 
blending 
3.3.3.1. Design of experiment 
Preliminary experiments were carried out to examine the effect of sampling 
strategies on the NIR spectral features of the powder with respect to blender 
speed and state of the powder during spectral acquisition. In order to eliminate 
the spectral differences due to complexity of texture in multi-component 
blends, a single component powder system of inhalation grade lactose, Inhalac 
230, was used. Inhalac 230 has an added advantage of narrow size 
distribution. The IBC was filled to approximately 60 % v/v of its capacity and 





Inhalac 230 powder and NIR spectra were collected in real time. The static 
spectra of the Inhalac 230 powder were also acquired at the start and end of 
the blending run, and were averaged for further analysis. 
D-optimal mixture design (Table 3) was used to obtain the blending runs for 
generation of MVC models. All the blending runs were performed in the IBC 
blender at 10 rpm for 30 min.  
 
Table 3: D-optimal mixture design for the blend experiments 
 
Blend components (% w/w) 
Run 
CPM lactose MCC MgSt 
1 6 52.5 40 1.5 
2 2 77.5 20 0.5 
3 2 77.5 20 0.5 
4 2 56.5 40 1.5 
5 6 72.5 20 1.5 
6 2 76.5 20 1.5 
7 2 76.5 20 1.5 
8 6 53.5 40 0.5 
9 2 57.5 40 0.5 
10 2 57.5 40 0.5 
11 6 73.5 20 0.5 
12 6 73.5 20 0.5 
13 6 53 40 1 
14 6 73 20 1 
15 6 62.5 30 1.5 
16 6 63.5 30 0.5 
17 2 57 40 1 
18 2 66.5 30 1.5 
19 4 54.5 40 1.5 
20 4 55.5 40 0.5 
21 4 74.5 20 1.5 
22 4 65 30 1 
23 4 65 30 1 
24 4 65 30 1 
* Gray shades indicate the runs used for testing the prediction performance of 




 3.3.3.2. MVC model development 
Out of the 24 runs generated using D-optimal mixture design, runs 3, 10 and 
23 were excluded from the MVC model development. Instead, they were used 
as independent blend runs to test the prediction abilities of the developed 
calibration models. Three different strategies were used to obtain the spectral 
data for MVC models as described below.  
3.3.3.3. MVC models based on static spectral acquisition after laboratory 
mixing 
Mixtures with respective quantities of CPM, lactose, MCC and MgSt for each 
calibration run were prepared with a batch size of 100 g. CPM and lactose 
were first premixed in a 250 mL glass bottle for 5 min using a vortex mixer 
(Ika, VX9/VXR, Germany). MCC and MgSt were then added to this premix 
and again mixed for 25 min by tumbling. These mixtures were then sub-
divided into 8 equivalent portions (each portion approximately 12 g) using a 
riffler (Retsch, Germany) and scanned by pouring onto the optical head. Each 
portion was scanned 5 times. Thus, for one calibration mixture, a total of 8 x 5 
or 40 spectra were acquired. These 40 spectra were averaged, and the resultant 
average spectrum was used as a representative spectrum for the respective 
calibration mixture. Adequacy of the mixing condition was confirmed by 
exhibition of minimal variances of NIR spectra of the sub-divided portions.    
3.3.3.4. MVC models based on static and dynamic spectral acquisition in 
the IBC  
Top bottom loading pattern was used while charging the blend components 





portions. Blend components were placed in layers as follows, lactose, drug, 
MCC, MgSt, and lactose. The batch size of each run was 5 kg, occupying 
about 60 % of the IBC volume. All the blending runs in the IBC were 
conducted for 300 rotations and NIR spectrum was captured with every 
rotation of the IBC.  
Each blending run was divided into 15 equal segments. The blender was 
stopped after every 20 rotations to collect the static spectral data of the blend 
in the IBC. In-line spectral acquisition was carried out when the blender was 
in motion to obtain the dynamic spectral data of the blend in the IBC. Thus, 30 
MVC models (15 from static spectral acquisition and 15 from dynamic 
spectral acquisition) were generated for each component per run of the D-
optimal runs used for MVC model development.    
3.3.3.5. In-line quantification of blend components 
The optimal MVC models for different blend components were uploaded into 
the Process Explorer using the Online Unscrambler Predictor (OLUP) 




 3.3.4. Study III-B: Alternative approach for robust and sensitive 
MVC model for powder blending 
3.3.4.1. Design of experiment 
A simplex lattice design of degree 5 and 21 mixture points was used to 
generate 126 calibration samples using a combination of each of the blend 
components at 6 different levels (Table 4).  
 
Table 4: Experimental design for generation of calibration samples for 
blending study 
 
Blend        
components 




Levels                              
(% w/w) 
μCPM 0 10 0, 2, 4, 6, 8, 10 
lactose 70 80 70, 72, 74, 76, 78, 80 
MCC 20 30 20, 22, 24, 26, 28, 30 
MgSt* 0 1.25 0, 0.25, 0.5, 0.75, 1.0, 1.25 
 
*MgSt was treated as a process variable owing to its lower concentrations in 
the blends while generating the mixture design. 
 
3.3.4.2. MVC model development 
Mixtures with respective quantities of μCPM, lactose, MCC and MgSt for 
each calibration sample were prepared in a batch size of 100 g. μCPM and 
lactose were first premixed in a 1 L high shear mixer (Microgral, Collette NV, 
Belgium) at an impeller speed of 300 rpm for 3 min. Next, the premix, MCC 
and MgSt were mixed by tumbling in a 250 mL glass bottle for 30 min. These 
mixtures were then sub-divided into 8 equivalent portions (approximately 12 
g) using a riffler (Retsch, Germany) and scanned by pouring onto the optical 





total of 8 x 5 or 40 spectra were acquired. These 40 spectra were averaged and 
the resultant average spectrum was used as a representative spectrum for the 
respective calibration mixture. The spectra obtained were smoothed using 
moving average smoothing with segment size of 3 and pre-processed with 
standard normal variate (SNV) followed by 1st derivative.  Partial least square 
(PLS) regression method was then used to build the MVC models for each 
component.  
3.3.4.3. Validation of MVC models 
Two approaches were used to validate the respective MVC models of each of 
the blend components. In the first approach, leave one out full cross validation 
was carried out to determine the number of PCs required to minimize the 
RMSECV and SEP. In the second approach, 22 independent validation blend 
samples spanning the calibration range of each component were prepared and 
scanned using a similar procedure to that of the calibration samples. All 
validations were carried out using the average spectra. Prediction results 
obtained for each of the components using the respective MVC models were 
compared against the reference gravimetric values.    
3.3.4.4. In-line quantification of blend components 
The optimal MVC models for different blend components were uploaded into 
the Process Explorer using the Online Unscrambler Predictor (OLUP) 
software. Detailed description can be found in section 3.3.2.3. 
3.3.4.5. Blending study  
The blending study was carried out to assess the developed MVC models for 
their capability to quantitatively estimate the blend components. The IBC bin 
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 blender was filled to approximately 60% fill level and rotated at 10 rpm as 
these conditions were reported to give better performance of bin blenders for 
blending cohesive blends (Sudah et al., 2002). A 5 kg powder blend 
comprising 4 % w/w μCPM, 72 % w/w lactose, 23 % w/w MCC and 1% w/w 
MgSt was used for the blending study. In order to impart the variability in 
distribution of blend components within the IBC, three different sets of 
blending operations were carried out. For blend A, μCPM was premixed with 
the entire portion of lactose in a 10 L high shear mixer (Ultima™ Pro 10, 
Collette NV, Belgium) at an impeller speed of 200 rpm for 3 min followed by 
blending in the IBC without the prism attachment. For blend B, μCPM was 
premixed with the entire portion of lactose in the high shear mixer at an 
impeller speed of 200 rpm for 3 min followed by blending in the IBC with the 
prism attachment. For blend C, premixing of μCPM with lactose was carried 
out by adding them together and then passing the powders through a 355 μm 
aperture size sieve followed by blending in the IBC with the prism attachment. 
Top bottom loading pattern was used while charging the blend components 
into the IBC to promote dispersive mixing of the cohesive blend formulation 
used in the present investigation. Blend components were placed in layers: 1.9 
kg drug: lactose premix, 0.575 kg MCC, 0.050 kg MgSt, 0.575 kg MCC and 
finally 1.9 kg drug: lactose premix. All the blending experiments in the IBC 
were conducted for 300 rotations and one single NIR spectrum was captured 
with every rotation of the IBC.  
3.3.4.6. Extent of μCPM adhesion and agglomeration after premixing 
After premixing in the high shear mixer or sieving process, drug: lactose 





examined under a scanning electron microscope (Phenome microscope, FEI 
Company, USA) to assess the extent of μCPM adhesion and agglomeration on 
the coarser lactose particles. 
3.3.4.7. Cohesive properties of the blends 
Avalanche flow measurements (Aero-Flow powder tester, 3250, TSI, Inc., 
USA) were carried out for all mixed blends after the blending operation. 
Samples weighing about 500 g were withdrawn for determination of the 
dynamic flow property of the blend samples. Avalanche flow index (AFI) and 
cohesive interaction index (CoI) were then subsequently calculated as 
described previously in section 3.2.2.7. 
3.3.4.8. Blend uniformity using UV spectroscopic method 
Ten samples from different locations of the IBC were collected at the end of 
the blending process using a stainless steel single point sampling thief 
(Sampling Systems, UK). Five samples weighing approximately 500 mg were 
taken out from two fixed levels (1 and 2) at each time point.  For level 1, the 
sampling thief was inserted to a depth of 10 cm from the top of the powder 
bed. For level 2, sampling depth was 20 cm. These samples were analyzed by 
a validated UV spectroscopy method for their μCPM content. The UV 
spectroscopic method is given in section 3.3.2.6. 
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 3.3.5. Study III-C: Monitoring of tabletting unit operation 
3.3.5.1. Calibration tablet manufacturing  
A simplex lattice design was used to generate 105 calibration samples (Table 
5). Calibration samples with a batch size of 100 g were prepared by mixing the 
respective components using a high shear mixer (Microgral, Collette NV, 
Belgium) followed by tumbling in a 250 mL glass bottle for 30 min. These 
mixing conditions were previously optimized for uniform distribution of blend 
components. At least 10 calibration tablets (each weighing 500 mg) were 
compressed per 105 calibration samples using a hydraulic press (Universal 
testing machine-Autograph AGE-100KN, Shimadzu, Japan) with 10 mm flat 
faced punches. 
 
Table 5: Experimental design for generation of calibration samples for 
tabletting study 
 
Components Lower limit       
(% w/w) 
Upper limit    
(% w/w) 
Levels                              
(% w/w) 
μCPM 0 10 0, 2, 4, 6, 8, 10 
Lactose 70 80 70, 72, 74, 76, 78, 80 
MCC 20 30 20, 22, 24, 26, 28, 30 
MgSt* 0 1. 50 0.50, 0.75, 1.00, 1.25, 1.50 
 
*MgSt was treated as a process variable owing to its lower concentrations in 
tablets while generating the mixture design 
 
3.3.5.2. Production batch tablet manufacturing   
A 5 kg powder batch comprising 4 % w/w μCPM, 72 % w/w lactose, 23 % 
w/w MCC and 1% w/w MgSt was mixed in an IBC bin blender (SP15, GEA 





lactose were premixed in 10 L high shear mixer (Ultima™ Pro 10, Collette 
NV, Belgium) at an impeller speed of 200 rpm for 3 min before proceeding to 
mix with MCC and MgSt in the IBC. The mixed blend was then emptied into 
a 10 L hopper for tablet compression in a 10 station rotary tabletting machine 
(Rimek, Karnavati, India) using 10 mm flat faced punches. The machine was 
operated at a speed of 10 rpm. The average tablet weight was 530 mg. 
3.3.5.3. Calibration and production (in-line) NIR spectral acquisition 
For calibration tablets, the punches and dies were removed and dies were 
replaced with the blank discs. The tablets were lined up near the tablet ejection 
area and the turret was rotated at 10 rpm. The NIR sensor was triggered while 
the tablets were passing underneath the measuring head of the probe.  
Reflection spectra were acquired through the fibre optic probe and processed 
on a computer. For in-line spectral acquisition during tabletting, a similar 
procedure was used with the punches and dies fixed. In order to exclude non-
sample data (when the NIR sensor was not triggered on the tablet surface), a 
trend qualification rule was set in the Process Explorer method setup which 
removed the non-representative spectra from the data stream.  
3.3.5.4. MVC model development  
The raw calibration spectra were pre-processed using SNV followed by 
derivative pre-processing. PLS regression technique was used to build the 
MVC models except for the signature wavelengths models for which MLR 
technique was used.  
Several sets of MVC models were developed using different spectral regions 
(980-1400, 1400-1900 and 980-1900 nm) and signature wavelengths for each 
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 components (μCPM -1124 nm, lactose -1538 nm, MCC – 1489 nm, MgSt - 
1408 nm) to find the best MVC model. Additional models were also built 
using the significant wavelengths obtained after Martens’ jack-knife 
significance test (Westad et al., 1999; Esbensen, 2005) was performed on the 
whole wavelength spectral data. In this test, under cross validation, several 
sub-models created which were based on all the calibration samples that were 
not kept out in the cross validation segment. For every sub-model, regression 
coefficients were calculated. For each wavelength, the difference between the 
regression coefficient in a sub-model and the regression coefficient for the 
total model (model based on all the samples) was calculated. The sum of the 
squares of the differences in all sub-models was calculated to obtain an 
expression of the variance of the estimate of regression coefficient in a sub-
model for a wavelength. A t-test was then applied to determine the 
significance of the estimate of regression coefficient in a sub-model. Resultant 
regression coefficients with uncertainty limits that corresponded to 2 standard 
deviations and/or those which did not cross the zero line were considered as 
significant variables. More detailed description of this test could be found in 
the reference (Esbensen, 2005). 
3.3.5.5. Validation of MVC models 
Leave one out full cross validation was carried out for all the MVC models. 
Additionally, external test set validation and validation according to ICH 
guidelines were carried out for the selected optimal models. For external test 
validation, at least 10 tablets (weighing 500 mg) per 34 independent validation 
tablets falling within the range of calibration tablets were prepared using the 





generating the calibration tablets. The spectra obtained from 10 tablets per 
validation samples were averaged and used for further processing. Respective 
test set validation models for each of the tablet component were then 
constructed and tested based on the calibration and prediction statistics.  
3.3.5.6. In-line quantification of tablet components 
The validated MVC models for each component were then uploaded into the 
Process Explorer using the Online Unscrambler Predictor (OLUP) software 
for in-line quantification of components. A detailed description could be found 
in section 3.3.2.3. 
3.3.5.7. Content uniformity of production tablets obtained using 
stratified sampling 
During production batch tabletting, tablets were collected immediately after 
in-line spectral acquisition into three separate containers. The containers were 
changed at every 30 minute interval.  At the end of the tablet production 
process, 30 tablets from each container were randomly withdrawn and 
weighed before performing further analysis. These tablets were then scanned 
in a dynamic manner using the same procedure as that for the calibration 
tablets. A laboratory validated UV spectroscopic method was used to 
determine the drug content uniformity of each batch of tablets. The UV 



















4. RESULTS AND DISCUSSION 
4.1. Study I: Optimization of optical interferometer for surface 
roughness characterization  
As the use of optical interferometry for surface characterization of lactose 
particles has not been widely investigated, it was imperative to validate and 
confirm the accuracy of surface roughness results obtained by this technique 
before employing it as a routine analytical tool. Hence, in this study, the 
results obtained with the optical interferometer were compared with those 
obtained using the well established surface characterization technique, i e. 
scanning probe microscopy.  
4.1.1. Scanning probe microscopy (SPM) 
The SPM images (Figure 6) showed evidently that the surface of DCL 40 was 
the roughest among the four lactose grades. More information regarding 
surface roughness of the lactose particles could also be gathered from the SPM 
images. Visual inspection of the images obtained with SPM revealed 
adherence of some tiny particles onto the larger particles of Inhalac 230. 
Nevertheless, differences between the surface roughness of Capsulac S and 
200M could not be clearly demarcated by qualitative assessments using SPM 
images. 
Surface roughness parameters values of the four lactose grades obtained from 
quantitative assessment of the various SPM profiles are shown in Table 6. 
From the quantitative results, it was found that Inhalac 230 and DCL 40 had 
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 the lowest and highest Ra values respectively, corroborating the results from 
the qualitative assessment of their surfaces by SPM images.  
 
 
Figure 6: Images obtained with the SPM for the lactose grades (A) Inhalac 
230, (B) Capsulac S, (C) 200M and (D) DCL 40.  
 
More importantly, quantifying surface roughness with Ra enabled 
differentiation between Capsulac S and 200M which was not that clear from 
the SPM images. In general, Ra values increased in the following order: 
Inhalac 230< Capsulac S< 200M< DCL 40.  Applications of fractal dimension 
(FD) and surface ratio (SR) for surface characterization of the lactose grades 
studied were found to be somewhat limited as their respective values for the 
different grades ranged very close to each other. 
Fractal analysis has been reported as the better method for assessing surface 
irregularity of rough particles and granules in several studies. However, work 





good discriminator for distinguishing between lactose carriers with fairly 
smooth surfaces. Nevertheless, the highest FD values obtained for DCL 40 
purported its highly irregular surface among all four lactose grades. FD and 
SR for the different lactose grades also followed a similar trend.  
 
Table 6: Roughness values of the lactose samples determined with SPM 
 
 
Lactose grade Ra (nm) FD SR 
Inhalac 230 406.0 (0.67) 2.036 (0.012) 1.139 (0.088) 
Capsulac S 417.0 (0.55) 2.048 (0.018) 1.187 (0.120) 
200 M 430.6 (0.47) 2.052 (0.012) 1.200 (0.061) 
DCL40 616.4 (0.24) 2.068 (0.017) 1.353 (0.136) 
 
Values in parentheses represent standard errors. 
 
4.1.2. Optical interferometry 
Qualitative assessment of the 3D images obtained from the optical 
interferometer (Figure 7) was found to be in good agreement with those 
obtained from SPM. Quantitative analysis results for surface roughness of 
different lactose grades are shown in Table 7. Roughness parameters, Ra and 
Rq, exhibited the following trend, from smoothest to roughest, Inhalac 230< 
Capsulac S< 200M< DCL 40. Since Rq values were obtained from squared 
height value, they were more sensitive to abrupt and random peaks and valleys 
than Ra which is an average of peaks and valleys throughout the dataset. 
Hence, Rq values presented more accurate and precise quantification of 
surfaces occurrences. Rq values were found to range from 1731 nm for 
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 Inhalac 230 to 2185 nm for DCL 40. Furthermore, a ratio of Rq/Ra which gives 
an idea of surface variability was used to determine the nature of surface 
occurrences. Results obtained for this ratio were found to range from 1.432 for 





Figure 7: Images obtained with the optical interferometer for the lactose 
grades (A) Inhalac 230, (B) Capsulac S, (C) 200M and (D) DCL 40. Red and 




The lowest ratio obtained for Inhalac 230 showed that there were no abrupt 
and random peaks or valleys on its surface indicating repetitive and regular 
surface morphology compared to other lactose grades employed. On the 
contrary, DCL 40 showed the highest Rq/Ra value of 1.488 indicating 
randomness and irregular surface morphology. This finding could be attributed 





by an agglomeration process which ultimately makes it of highly irregular 
morphology.  
 
Table 7: Surface roughness parameters and roughness ranking of the 4 lactose 
grades 
 
Grade Ra (nm) Rq (nm) Rq/Ra 
Inhalac 230 1268.844 (41.638) 1731.028 (50.591) 1.432 (0.022) 
Capsulac S 1290.032 (50.670) 1829.849 (47.993) 1.459 (0.091) 
200 M 1471.979 (64.371) 2173.152 (78.308) 1.477 (0.194) 
DCL40 1602.874 (84.03) 2185.705 (68.79) 1.488 (0.104) 
 
Values in parentheses represent standard errors. 
 
 
The results obtained with optical interferometry corroborated adequately with 
the traditional well established SPM. However, the results obtained for the Ra 
and Rq parameters from optical interferometry were almost double that 
obtained from SPM. This trend in results was attributed to the relatively larger 
scan area utilized to calculate the roughness parameters (15 X 15 µm for SPM 
and 30 X 30 µm for optical interferometry). Hence, optical interferometry is 
found to be suitable for use as a routine analytical tool for surface 
characterization of lactose particles.  
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 4.2. Study II: Surface modification of lactose particles 
When evaluating powder properties, environmental conditions are usually a 
major concern as even small variations in humidity or temperature can 
sometimes affect the properties. Therefore, controlling the environmental 
conditions is of paramount importance to ensure that the inherent properties of 
the bulk powder remain constant throughout the experiments. Hence, the 
conditions of 25°C and 50% relative humidity which are generally considered 
most desirable were maintained during the experiments. Effect of particle size 
was minimized by ensuring that all grades of lactose used had similar size 
fractions (75-100 μm). The use of similar size fraction lactose grades enabled 
the influence of particle surface roughness on the capacity of the lactose 
grades to retain micronized drug particles to be investigated exclusive of other 
physical properties. 
4.2.1. Molecular properties 
4.2.1.1. Differential scanning calorimetry (DSC) 
The possibility of altering the crystallinity of lactose grade used (α-lactose 
monohydrate) by the IPA-water mixture was a concern. Therefore, DSC 
analysis was carried out to assess the changes in crystallinity of the lactose 
grades. Thermograms of each lactose grade (INH-S, INH-C, INH-RR and 
INH-R) (Figure 8) showed characteristic endothermic peaks of α-lactose 
monohydrate at around 140°C and 210°C. Furthermore, thermograms of INH-
S, INH-R and INH-RR were comparable to that of INH-C, confirming that the 
treatments used to modify particle surfaces did not alter the crystallinity of α-









 Figure 8: DSC thermograms of the lactose grades (A) INH-S, (B) INH-C, (C) 





4.2.2. Particulate properties 
4.2.2.1. Shape analysis 
Results obtained for shape analysis are as shown in Table 8. Particles from all 
the lactose grades had similar degree of elongation as indicated by the narrow 
range of aspect ratio (1.371 to 1.386).  Similar results were obtained for 
roundness (1.183 to 1.211). One-way analysis of variance (ANOVA) showed 
that aspect ratio and roundness values were not significantly different among 
the lactose grades analyzed (ANOVA, p > 0.05). Thus, the effect of shape on 
physical properties of the lactose grades was negated. 
4.2.2.2. Specific surface area (SSA) measurement 
Although SSA values were not significantly different among the lactose 
grades analyzed (ANOVA, p > 0.05), the trend of SSA (Table 8) in increasing 
order could be established as:  INH-S, INH-C, INH-R and INH-RR. These 
results suggested that INH-RR and INH-R were the rougher lactose grades as 
all the grades were of the same size fraction (75-100 µm). The non significant 
differences observed could be attributed to the basic principles of the method 
where it assumes that particles are perfect spheres and thus might be difficult 
to apply to non-spherical particles as the area difference between the 
experimental and theoretical values might be due to particle shape and not due 







Table 8: Physical characterization of lactose grades 
 
Shape Flow Lactose 




AFI CoI  AR (°)** HR CI 
1.378  1.190  0.434  
INH-S 











1.385  1.183  0.487  
INH-C 











1.371  1.188  0.477  
INH-R 











1.382  1.211  0.560  
INH-RR 





















 4.2.2.3. Surface roughness of lactose particles 
 Scanning electron microscopy (SEM) 
The effect of surface modification on each lactose grade could be qualitatively 
visualized from the SEM micrographs (Figure 9).  It was observed that INH-S 
had the smoothest surface and INH-RR had the roughest surface. The trend of 
increasing surface roughness can be qualitatively established as INH-S, INH-
C, INH- R and INH-RR. 
 
 
Figure 9: Scanning electron micrographs of the lactose grades (A) INH-S, (B) 
INH-C, (C) INH-R and (D) INH-RR (1000x magnification). 
 
 Optical interferometry 
SEM micrographs (Figure 9) and images obtained from optical interferometer 
(Figure 10A-i, 10B-i, 10C-i, 10D-i) showed that lactose particles had similar 







Figure 10: Images obtained with the optical interferometer of the lactose 
grades. (A) INH-S: i) top view, ii) horizontal line profile, iii) vertical line 
profile; (B) INH-C: i) top view, ii) horizontal line profile, iii) vertical line 
profile; (C) INH-R: i) top view, ii) horizontal line profile, iii) vertical line 
profile; (D) INH-RR: i) top view, ii) horizontal line profile, iii) vertical line 
profile. Red and blue color indicates the extreme high extreme deep points in 







Figure 10 (Continued): Images obtained with the optical interferometer of the 
lactose grades. (A) INH-S: i) top view, ii) horizontal line profile, iii) vertical 
line profile; (B) INH-C: i) top view, ii) horizontal line profile, iii) vertical line 
profile; (C) INH-R: i) top view, ii) horizontal line profile, iii) vertical line 
profile; (D) INH-RR: i) top view, ii) horizontal line profile, iii) vertical line 
profile. Red and blue color indicates the extreme high extreme deep points in 






The optical interferometric images and their corresponding line profiles 
(Figure 10) elaborated further the surface roughness of the lactose particles. 
Results obtained for quantitative roughness parameters for the lactose grades 
are depicted in Table 9. Rq values were found to range from 1731 nm for 
INH-S to 2155 nm for INH-RR. One-way ANOVA showed that Ra and Rq 
values were significantly different among the lactose grades analyzed 
(ANOVA, p < 0.05). The Rq/Ra values (Table 9) also indicated the same trend 
confirming smoother and more regular surface of INH-S and rougher and 
irregular surface of INH-RR. Thus, the diversity of the surface roughness of 
lactose grades used for this study was confirmed. Based on Ra and Rq results, 
a trend was established for lactose particles exhibiting smoothest to roughest 
surface, INH-S, INH-C, INH-R, and INH-RR.  
The lowest Ra, Rq and Rq/Ra values were obtained for INH-S (Table 9) 
indicating smoother and more regular surface. This could be attributed to the 
simultaneous occurrences of the fluidization, introduction of spray liquid and 
rapid drying of lactose particles within the product chamber of the precision 
coater during surface modification of lactose particles by precision coating. 
Higher degree of smoothness was achieved for INH-S as the spray liquid 
employed was just a mixture of IPA-water. The solvent mixture has 
considerably more dissolving capacity than the lactose dispersion used for 
INH-R and ultimately showed better smoothening action. Moreover, as the 
spray liquid dried up, the dissolved lactose re-crystallized to fill up the valleys 
making the surface even smoother (Chan et al., 2003).  
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 Table 9: Surface roughness parameters and ranking of the lactose grades 






































Values in parentheses represent standard errors. * Rank 1 represents the 
smoothest surface; Rank 4 represents the roughest surface (based on Ra and 
Rq). 
 
For the roughest INH-RR, the valley-filling phenomenon could be traced as 
the attributing factor for surface smoothening effect, but the spray solution 
played an additional role of being a binding agent that bound the lactose fines 
from the feed material on to the smoothened surfaces of the larger Inhalac 230 
particles. A smoothened surface increased the total contact surface area for 
attachment of lactose fines, and hence, increased the interactive force between 
them (Otsuka et al., 1988; Iida et al., 1993; Heng et al., 2000; Zeng et al., 
2001). Consequently, lactose fines were deposited onto the smoothened 
Inhalac 230 particles and resulted in the production of INH-RR with the 
roughest surface (highest Ra and Rq values as shown in Table 9) among the 4 





The spray liquid for INH-R, saturated lactose IPA-water solution containing 
dispersed micronized lactose particles was not as effective as a pure mixture of 
IPA-water (as in the case of INH-S and INH-RR) in dissolving the protrusions 
on the Inhalac 230 surfaces. The saturated spray solution acted as a binding 
agent for binding micronized lactose particles deposited onto the surfaces of 
Inhalac 230. Moreover, the saturated spray solution filled up the valleys as 
well as the spaces between the solid micronized lactose particles deposited on 
Inhalac 230 particles and upon drying, re-crystallized out. These two 
phenomena were responsible for the highly irregular (Rq/Ra value of 1.723) 
but relatively less rough surfaced INH-R (Rq value of 2122 nm) compared to 
INH-RR (Rq value of 2155 nm) (Table 9). 
4.2.3. Bulk properties: flow assessment 
4.2.3.1. Dynamic flow characterization using avalanche flow tester 
The avalanche flow properties of the lactose grades are as shown in the form 
of strange attractor plots (Figure 11). The corresponding AFI and CoI values 
for each grade are depicted in Table 8.  
In avalanche flow characterization, free flowing powders showed strange 
attractor plots that were closer to the origin and with less scatter (Soh et al., 
2006). In the present study, the strange attractor plots obtained clearly 
demonstrated the influence of surface roughness on the avalanche flow of the 
lactose grades. Smoother INH-S, exhibited the most condensed strange 
attractor plot and consequently, excellent flow whereas INH-R and INH-RR 
showed inferior flow as can be seen from their corresponding widely spread 
strange attractor plots. The influence of surface roughness on flow properties 
of lactose grades was further confirmed by corresponding AFI and CoI values. 
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 Rougher surfaced INH-RR and INH-R exhibited low AFI values indicating 
their poorer flow. On the other hand, the relatively smoother surfaced INH-S 
exhibited highest AFI value and consequently, was best flowing. Furthermore, 
the CoI values which were used to demonstrate the cohesiveness of the 
powders also suggested a similar trend. INH-RR and INH-R with rougher 
surfaces were more cohesive than the smoother surfaced INH-S. Overall, 
based on the AFI and CoI values obtained for the lactose grades, a trend could 
be established for their flow properties in descending order, as  INH-S > INH-
C > INH-R > INH-RR.  
 
 
Figure 11: Strange attractor plots of the lactose grades (A) INH-S, (B) INH-C, 






4.2.3.2. Angle of repose and compressibility studies 
Angle of repose values (Table 8) showed correlation with surface roughness as 
smoothest surfaced INH-S exhibited best flow while roughest INH-RR 
exhibited somewhat inferior flow property among the grades analyzed.  
The results obtained for CI and HR were less distinctive. All the lactose grades 
investigated may be classified as having fair flow properties according to the 
classification proposed by Staniforth and Aulton (2001). This is probably 
because of the wider margins used for setting the flow classification limits. 
However, the trend in roughness measurements obtained was closer to that of 
flow results, affirming the poorer flow properties of rougher lactose grades 
(INH-RR and INH-R) compared to that of the relatively smooth lactose grades 
(INH-S and INH-C). 
4.2.3.3. Powder bed porosity 
Results obtained for powder bed porosity (Table 8) further demonstrated that 
as the surface roughness of lactose particles increased, the powder packed less 
densely and therefore, there was increased void volume between particles. The 
roughest INH-RR lactose grade exhibited highest porosity value and 
smoothest INH-S had the smallest porosity value.   
4.2.4. Surface roughness and bulk flow of lactose particles: 
multivariate data analysis 
Poorer flow properties exhibited by the rougher grades of lactose could be 
explained in terms of the presence of inter-particulate frictional forces. As the 
surface became rougher, the frictional force between the lactose particles 
increased and consequently, resulted in poorer flow (Ferrari et al., 2004). 
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 Moreover, interlocking of the constituent particles could be anticipated with 
the increase in surface roughness and undulations which contributed to higher 
frictional forces for sliding against each other in bulk powder movements. As 
described in the section 4.2.2.3, INH-RR particles were rougher with uneven 
surface patterns because of the random deposition of fine lactose particles on 
the particle surfaces during the precision coating process. In order to identify 
the underlying factors contributing to the flow properties exhibited by the 
various lactose grades, multivariate data analysis was carried out. Considering 
the nature of the dataset, PLS regression was used to determine the correlation 
between roughness and flow parameters. Roughness parameters were treated 
as predictors (X) and flow parameters as responses (Y). Resultant scores 
(Figure 12A) and correlation loadings (Figure 12B) plot were used to group 
the lactose grades and determine any possible correlations between X and Y 
variables. From the scores plot, lactose grades could be classified primarily 
into two groups: group one constituted the grades which were located at the 
right hand side from the center while group two constituted the grades at the 
left. Thus, INH-RR and INH-R were similar to each other but different from 
INH-S and INH-C. Among all the grades, INH-S and INH-RR were the 
farthermost from each other indicating significant differences exhibited by 
these grades. These findings in differences could be easily visualized from the 
corresponding correlation loadings plot which showed the spread of X and Y 
in two dimensions (Figure 12B). In the loadings plot, predictors Ra, Rq and 
Rq/Ra are at the same direction from the center as that of angle of repose, CoI, 
CI and HR, indicating their positive correlations. AFI was the lone response 





negative correlation. In other words, AFI showed an increase with the 
decreases in Ra, Rq and Rq/Ra values. Thus rougher surfaced (high Ra, Rq 
and Rq/Ra values) INH-RR and INH-R particles exhibited poorer flow 
properties (high values of angle of repose, CoI, CI, HR and low values of AFI) 
and hence were grouped together in the scores plot away from the smoother 
lactose grades (Figure 12A). In contrast, having the smoothest surface and best 
flow property, INH-S was situated in the opposite direction farthest from INH-
RR in the scores plot. 
 
Figure 12: PLS regression analysis of roughness and flow properties exhibited 
by lactose grades. (A) Scores plot (B) Correlation loadings plot. 
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 4.2.5. Assessment of surface roughness for retaining μCPM 
particles 
The SEM micrographs (Figure 13) of the blend particles showed that the 
μCPM adhered to lactose particles to different extent depending on the surface 
roughness of the lactose particles. Visual examination showed that as the 
surface roughness of the carrier particles increased from INH-S to INH-RR, 




Figure 13: Scanning electron micrographs depicting adhesion of μCPM onto 
the lactose particles with different surface roughness (1000X magnification): 
(A) INH-S, (B) INH-C, (C) INH-R, and (D) INH-RR.  Adhered μCPM 
particles are depicted within the circles. 
 
However, this may not guarantee the capacity of the carrier particles to retain 
the same amount of μCPM particles on their surfaces upon vibration or 





capacity of the different surfaces to retain μCPM particles by subjecting them 
to vibration using a mechanical sieve shaker. As reported previously, sieving 
could cause attrition among the coarse particles and may cause size reduction. 
Hence, it was imperative to select sieving conditions to bring about 
segregation without compromising the particle size attributes through attrition. 
Preliminary studies carried out confirmed that there was no significant change 
(p > 0.05, paired t test) in particle size of the lactose particles after vibrating 
for 10 min at amplitude of 1 mm.        
Percentages of μCPM retained after 5 and 10 min vibration periods are shown 
in Figure 14. It was observed that the capacity to retain the μCPM particles 
reduced with a decrease in surface roughness, i.e. from INH-RR, INH-R to 
INH-C, and with increase in sieving time. These results coincided with the 
findings reported previously by Swaminathan and Kildsig (2000).    
 
Figure 14: Percentage of μCPM retained on the lactose particles with different 
surface roughness after 5 and 10 min vibration. 
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 INH-RR was postulated to retain the μCPM particles by entrapment. The 
μCPM particles were likely filling the crevices on the surface of rough INH-
RR lactose particles. This greatly increased the total surface area of contact 
and entrapment opportunities on the carrier particles for the μCPM particles. 
Furthermore, the high porosity of the INH-RR powder bed provided spaces for 
fines to be held within. The high void volume in the powder bed enabled 
μCPM particles to be entrapped in the crevices of the roughened surfaces 
when subjected to vibratory forces, and hence the particles were prevented 
from being dislodged to be passed through the sieve. Therefore, as the porosity 
decreased from INH-RR to INH-C due to the decrease in surface roughness, a 
similar trend in decreasing capacity to retain μCPM particles was observed. 
Interestingly, INH-S exhibited an appreciable capacity to retain μCPM 
particles. Although INH-S had the lowest porosity and was smoothest, it had 
the capacity to retain μCPM particles almost comparable to INH-RR. This was 
most likely due to the smoother surface of the lactose particles that had 
allowed close flat face - flat face contact with the μCPM particles. Since inter-
particulate attractive forces such as van der Waals forces increase with the 
decrease in distances between the interacting particles, close contact of carrier 
particles and μCPM particles result in strong adhesion force between them 
(Otsuka, 1988). Furthermore, smooth surfaces increased the net adhesion of 
the μCPM particles onto the carrier particles. This, in turn, increased the 
binding forces between them and gave rise to the higher capacity to retain 
μCPM particles. Based on the findings, a graphical representation of the 





shown in Figure 15. Powders vibrated for 10 min also exhibited similar trend 
confirming that either increased contact area or entrapment by the lactose 
particles influenced their capacities to retain μCPM particles.  
 
Figure 15: Schematic representation of interaction of μCPM particles on the 
surface of lactose particles (A) INH-S, (B) INH-C, (C) INH-R and (D) INH-
RR.  represents μCPM particle and  represents lactose particle. 
 
In summary, a linear relationship was exhibited by the surface roughness of 
lactose particles with the bulk powder flow. Capacity of lactose carrier 
particles to retain μCPM particles decreased with decreasing surface 
roughness. However, if the degree of surface roughness decreased to a certain 
extent, a strong capacity to retain μCPM particles became evident. These 
findings suggest that the excipients should be carefully selected in order to 
improve performances of ordered mixtures. Keeping these findings in mind, in 
the next studies, lactose was preferred as the excipient of choice for 




 4.3. Study III: In-line monitoring of tablet manufacturing 
process using NIR spectroscopy 
4.3.1. NIR spectra of tablet components 
In NIR spectroscopy, spectral pre-processing and spectral regions to be used 
for building the MVC models are of crucial importance. Spectral pre-
processing is usually performed to remove unwanted scattering features 
incorporated in NIR spectra which are often due to the differences in sizes of 
the constituent particles of the sample and other interfering factors which do 
not provide any information about the chemical concentration of the analyte of 
interest (Blanco et al., 1997; Olinger et al., 1993). On the other hand, while 
generating a MVC model, it is a general principle that a parsimonious model, 
i.e. a model with fewer components and variables than the full components or 
variables, will result in optimal calibration statistics since the number of model 
parameters is sparse. However, it could be advantageous in some cases to keep 
some of the wavelengths (X) with even the slightest correlation (with respect 
to the component (Y)) to span the multi-dimensional space especially when 
the sample is moving, or varies rapidly with time (Hongis, 1992; Beebe et al., 
1998, Esbensen, 2005).  
As can be seen from Figure 16, all the tablet components exhibited regions of 
meaningful correlations throughout the range but almost all the regions were 
overlapping. Thus, different strategies were used to determine the appropriate 
spectral pre-processing and spectral regions for obtaining the optimal MVC 
models. The applications of spectral regions and spectral pre-processing are 











Figure 16: (A) Raw and (B) SNV followed by 1st derivative pre-processed 
NIR spectra of the individual blend/ tablet components. In these plots, C, L, P, 
and M represents CPM, lactose, MCC and magnesium stearate respectively. 
Number 1 represents the materials used for study III-A. Number 2 represents 
the materials used for study III-B and III-C, respectively. X and Y axes 
represent the wavelength and absorbance, respectively. 
96 
 
 4.3.2. Monitoring of blending unit operation 
The NIR sensor with a diode array detector used for in-line spectral 
acquisition enabled quantitative characterization of the dynamic and chaotic 
blending process at a very fast speed, without any spectral artefacts such as 
spectral shifting and scattering effects due to constant movement of powder on 
the optical head during blending. The NIR sensor was triggered at every 
rotation and 10 raw energy spectra were captured and subsequently converted 
to one reflection spectrum. Hence, the individual spectrum obtained at each 
rotation was more representative of the actual state of powder falling on the 
optical head as spectral acquisition was carried out when the powder bed 
within the IBC was in motion. The sampling data (NIR spectra) was obtained 
at a very short intervals (at every rotation of the bin blender) and although the 
sensor was fixed at one particular position, the greater volume of air available 
to fluidize the powder bed within the IBC (IBC was filled to approximately 
60% v/v of total capacity for all the blending runs carried out in this study) 
had made it possible to achieve randomness in sampling locations. Thus, with 
the usage of the IBC bin blender equipped with in-line NIR sensor, it was 
possible to satisfy Allen’s golden rules of sampling which state that the blend 
samples should be obtained at very short intervals of time from multiple 
locations and when the process is being carried out (Lantz and Schwartz, 
1981). 
4.3.3. Study III-A: Calibration sampling paradox in powder blending 
The purpose of building MVC models is to determine the chemical 





spectral data. This is usually achieved by obtaining calibration samples that 
cover the anticipated formulation variables. Such information in combination 
with their corresponding reference values are then employed to develop 
models for future predictions. In this investigation, the main thrust was to 
examine if sampling strategies influence the NIR spectral features and 
prediction performance of the MVC models. The spectra used for building the 
MVC models were pre-processed using SNV followed by 1st derivative 
technique. This spectral pre-processing was used to remove unwanted 
scattering features incorporated in the NIR spectra which are often due to the 
differences in the size of the constituent particles and other interfering factors 
which do not provide any information about the chemical concentration of the 
analyte of interest. 
4.3.3.1. Effect of sampling strategies on NIR spectra 
Careful examination of the Inhalac 230 NIR spectra obtained using different 
strategies showed the exhibition of spectral differences as illustrated in Figure 
17. Spectral differences were quite distinct towards the high wavelength 
region. PCA of the spectra obtained in three different modes was performed. 
Figure 18 showed the 3D scores plot of the three spectral sets and revealed 
three distinct clusters within the scores plot. Furthermore, the spectra obtained 
in dynamic manner were found to be closer to one another than to the spectra 
acquired in static mode. The reason for the observed difference could be due 
to the difference in sample presentation for the dynamic and static sample. 
Considering the spectral differences between dynamic and static spectra, it 
was imperative to further investigate the effect of sample presentation 





Figure 17: Spectral differences observed with Inhalac 230 between the 
different sampling strategies. In these plots, X and Y axes represent the 





Figure 18: 3D scores plot for the spectra obtained with different spectral 
acquisition modes after PCA. ST represents spectra acquired when the IBC 
was in static position; D-10 and D-15 represent the spectra obtained in-line 






4.3.3.2. Effect of sampling strategies on calibration statistics  
D-optimal mixture design was adopted to impart formulation variability to the 
calibration samples. Moreover, calibration samples were obtained from the 
actual process. Thus, an attempt was made to produce samples which were 
relevant, representative and encompassed the anticipated combination of blend 
components during the actual process. Considering the complexity of the 
formulation blend, PLS regression technique was preferred over the MLR 
technique for building MVC models using spectra obtained by all three 
strategies. Raw NIR spectra of 980-2100 nm wavelength range corresponding 
to the calibration samples obtained were pre-processed with SNV followed by 
1st derivative. PLS models were built to correlate the blend components with 
the NIR spectra. Leave one out full cross validation was performed to 
determine the number of PCs required to minimize SEP values. Statistics 
obtained for MVC models with PLS regression method are summarized in 
Tables 10, 11 and 12.  
From the results, it can be seen that the laboratory mixed models were less 
accurate compared to IBC models in terms of their prediction performance. 
The numbers of PC and RMSECV values obtained were much higher than 
those of the IBC models for all the blend components. Improved calibration 
statistics with the IBC models could be attributed to more efficient mixing of 
the cohesive blend in an IBC. The IBC used in this study has an added 
advantage of the prism attachment which actually increases the rate of powder 
turnover and occurrences of failure regions because of its divisive action 
which is favorable for rapid attainment of uniformity (Sudah et al., 2002, 





dynamic models showed further improvement in calibration statistics. These 
results could be explained in the context of addition of high degree of 
variability in the MVC models as the spectra were acquired in real time. Based 
on the statistics obtained with IBC based models, MVC models of each 
component were ranked and those with the minmal error of prediction, and at 
the same time, larger R2 values were identified as best models and further used 
for prediction of the independent runs (3, 10 and 23). The models with the 
bold statistics in Tables 11 and 12 were identified as the best MVC models.    
 
Table 10: Statistics obtained for MVC model of each blend component with 
PLS regression method 
 
Blend components  PC X Y R2 RMSECV 
CPM 7 98.64 96.97 0.969 0.519 
lactose 3 98.31 98.28 0.983 1.580 
MCC 2 95.98 96.92 0.969 1.608 
MgSt 5 98.31 98.40 0.984 0.067 
 




Table 11: Statistics obtained for MVC model of CPM, lactose, MCC and MgSt based on static spectral acquisition in IBC with 
PLS regression method 
 
CPM lactose MCC MgSt Time 
(min) PC X Y R2 RMSECV PC X Y R2 RMSECV PC X Y R2 RMSECV PC X Y R2 RMSECV 
2 3 87.36 90.53 0.91 0.70 3 91.49 90.53 0.91 3.72 4 95.16 91.95 0.92 3.72 2 87.98 54.21 0.54 0.34 
4 4 96.55 90.13 0.90 0.81 3 94.03 94.61 0.95 2.97 4 96.5 90.01 0.90 4.10 3 93.42 67.06 0.67 0.35 
6 6 97.79 98.04 0.98 0.92 3 95.49 91.04 0.91 3.57 3 94.28 95.71 0.96 2.65 3 88.09 62.38 0.62 0.40 
8 6 97.88 99.1 0.99 0.65 4 96.35 94.21 0.94 3.69 3 96.54 93.41 0.93 2.93 4 96.58 93.84 0.94 0.17 
10 5 97.59 99.48 0.99 0.32 2 95.31 91.93 0.92 2.90 2 94.2 87.51 0.88 3.54 4 97.1 86.19 0.86 0.32 
12 5 97.85 99.18 0.99 0.33 3 96.03 95.65 0.96 2.66 1 86.59 92.74 0.93 2.55 4 97.27 92.01 0.92 0.23 
14 6 97.38 97.93 0.99 0.49 6 98.48 99.56 0.99 2.24 3 96.23 96.05 0.96 2.41 4 97.26 89.33 0.89 0.26 
16 4 97.34 96.81 0.97 0.68 5 98.07 98.92 0.99 2.12 3 96.66 95.51 0.96 2.61 4 97.63 97.16 0.97 0.12 
18 6 94.1 99.7 0.99 0.62 5 97.95 99.16 0.99 2.04 5 98.08 99.3 0.99 2.12 4 96.87 90.39 0.90 0.24 
20 4 96.78 96.74 0.97 0.54 4 97.38 97.71 0.98 2.32 4 97.5 99.01 0.99 1.79 4 92.31 96.04 0.96 0.23 
22 4 97.44 97.09 0.97 0.60 4 96.87 97.77 0.98 2.48 4 97.65 98.27 0.98 1.94 7 98.89 99.83 0.99 0.09 
24 5 98.1 98.34 0.98 0.54 5 97.25 98.92 0.99 2.56 3 96.85 96.96 0.97 2.23 6 98.17 99.57 0.99 0.11 
26 4 96.54 97.02 0.97 0.58 4 96.32 97.19 0.97 3.17 3 96.28 96.22 0.96 2.40 4 96.69 98.84 0.99 0.10 
28 5 97.37 98.8 0.99 0.47 4 96.89 95.84 0.96 3.29 3 95.89 96.23 0.96 2.70 5 98.41 99.24 0.99 0.10 
30 4 97.4 96.77 0.97 0.62 4 97.68 98.38 0.98 1.93 4 97.68 98.6 0.99 1.73 4 97.33 98.65 0.99 0.10 
 
X and Y represent the X and Y explained variances by the respective PCs. Models with the bold statistics indicate the best 





Table 12: Statistics obtained for MVC model of CPM, lactose, MCC and MgSt based on dynamic spectral acquisition in IBC with 
PLS regression method 
 
CPM lactose MCC MgSt Time 
(min) PC X Y R2 RMSECV PC X Y R2 RMSECV PC X Y R2 RMSECV PC X Y R2 RMSECV 
2 4 94.68 87.83 0.88 0.97 4 93.22 92.38 0.92 4.08 3 92.72 87.42 0.87 4.06 2 89.58 80.01 0.80 0.24 
4 3 95.88 93.62 0.94 0.58 3 93.17 96.33 0.96 2.37 3 93.3 96.25 0.96 2.38 3 90.85 84.54 0.85 0.22 
6 3 96.44 96.72 0.97 0.41 3 95.14 98.23 0.98 1.57 4 97.49 99.15 0.99 1.15 3 92.13 79.56 0.80 0.25 
8 2 95.29 96.69 0.97 0.39 4 97.71 98.54 0.99 1.55 4 97.74 98.8 0.99 1.35 5 98.15 98.64 0.99 0.09 
10 3 96.02 98.42 0.98 0.31 4 97.27 98.67 0.99 1.63 4 97.33 98.83 0.99 1.47 5 98.2 98.62 0.99 0.10 
12 5 98.11 99.5 0.99 0.25 4 97.31 98.02 0.98 2.09 4 97.72 99.22 0.99 1.25 5 98.01 98.79 0.99 0.09 
14 5 97.97 99.6 0.99 0.25 4 97.61 99.28 0.99 1.29 4 97.34 98.25 0.98 1.95 5 98.13 99 0.99 0.09 
16 4 97.32 99.77 0.99 0.18 4 97.49 99.06 0.99 1.38 4 97.66 99.34 0.99 1.18 5 98.1 98.96 0.99 0.09 
18 4 97.00 99.53 0.99 0.21 4 97.56 99.24 0.99 1.25 4 98.42 99.3 0.99 1.02 5 98.12 99.18 0.99 0.09 
20 3 96.05 97.76 0.98 0.37 4 98.49 99.05 0.99 1.22 4 96.52 99.37 0.99 1.09 5 97.99 99.03 0.99 0.09 
22 4 97.19 98.81 0.99 0.34 2 94.78 98.29 0.98 1.37 5 97.9 99.62 0.99 1.01 6 98.79 99.67 0.99 0.07 
24 4 96.94 98.63 0.99 0.34 4 97.03 99.18 0.99 1.26 4 97.09 99.41 0.99 1.12 6 98.86 99.76 0.99 0.06 
26 3 96.19 98.28 0.98 0.30 4 96.41 99.16 0.99 1.45 5 96.97 99.69 0.99 1.09 6 98.68 99.76 0.99 0.06 
28 3 95.96 98.07 0.98 0.32 4 96.8 98.9 0.99 1.50 4 97.6 98.78 0.99 1.59 6 98.63 99.73 0.99 0.05 
30 4 97.40 96.77 0.97 0.62 4 97.68 98.38 0.98 1.93 4 97.68 98.6 0.99 1.73 4 97.33 98.65 0.99 0.10 
 
 * X and Y represent the X and Y explained variances by the respective PCs. Models with the bold statistics indicate the best 
models selected for testing the independent test blends.
 
 
4.3.3.3. Effect of sampling strategies on prediction performance of MVC 
models 
The D-optimal runs, 3, 10 and 23, were used to test the prediction performance 
of the models built using the different strategies. The optimized PLS models 
obtained from the three different strategies were used to predict the 
concentration of blend components in real time during the blending process. 
The real time prediction of each of the blend components are depicted in 
Figures 19 to 22. Prediction results obtained in real time showed some 
interesting findings.  
 Prediction results of CPM 
Laboratory mixed static models resulted in predictions of CPM content that 
were significantly higher than the target/expected values. MVC models 
prepared using blend samples within the IBC resulted in desirable prediction 
results. Prediction results obtained with the dynamic model exhibited low 
variations and were very close to the target values of the test formulations. The 
possible attributes behind these results could be the differences in the sample 
presentation during MVC model preparation and real time blending 
experiments. The calibration samples used for building the dynamic MVC 
models were exactly the same as that of real time blending experiments 
whereas static IBC calibration samples had only resemblance of being blended 
in the same blender except that the spectral acquisition was carried out when 
the blender was in static position. In contrast, the MVC models obtained using 
laboratory mixed calibration samples did not exhibit much similarity, apart 




Figure 19: Prediction results of CPM obtained using different strategies (A) 
run-03, (B) run-10 (C) run-23 with laboratory mixed static (SL), IBC mixed 
static (SI) and IBC mixed dynamic (DI) MVC models. Red line ( ) 







Figure 20: Prediction results of lactose obtained using different strategies (A) 
run-03, (B) run-10 (C) run-23 with laboratory mixed static (SL), IBC mixed 
static (SI) and IBC mixed dynamic (DI) MVC models.  Red line ( ) 







Figure 21: Prediction results of MCC obtained using different strategies  (A) 
run-03, (B) run-10 (C) run-23 with laboratory mixed static (SL), IBC mixed 
static (SI) and IBC mixed dynamic (DI) MVC models.  Red line ( ) 











Figure 22: Prediction results of MgSt obtained using different strategies  (A) 
run-03, (B) run-10 (C) run-23 with laboratory mixed static (SL), IBC mixed 
static (SI) and IBC mixed dynamic (DI) MVC models. Red line ( ) 
represents the target concentration of the respective component. 
  Prediction results of lactose 
Static MVC models obtained using laboratory mixed calibration samples 
resulted in under predictions of lactose content for all the three runs. 
Moreover, the results were highly variable, and the degree of variability 
worsened with the increase in concentration of lactose in the formulation. 
Dynamic IBC models showed the best prediction performance followed by 
static IBC. Unlike CPM and MgSt, lactose prediction results were quite 
consistent and occurrences of aberrant prediction values were seldom 
observed. This could be attributed to its presence as a major component (52.5 
to 77.5 % w/w) in the bulk powder blend at the calibration and prediction 
stages which had enabled the blend to achieve uniform texture (homogeneity) 
rapidly.        
 Prediction results of MCC 
In contrast to the CPM and lactose results, predictions results obtained with 
dynamic models for MCC were highly variable. The reason for these observed 
results could be the highly irregular morphology of the MCC particles. MCC 
particles are essentially highly irregular shaped fibrous particles and are 
known to produce high scattering effect. This could be further confirmed from 
the trend observed with the concentration and variability of MCC predictions 
in all the three runs. In addition to this, run-3 with lower concentration of 
MCC exhibited large variations in predicted values. These variations were 
attributed to the non-uniform texture of the powder blend falling on the sensor 
at every rotation rather than the low amount of MCC in the formulation per se. 
However, when the MCC concentration was increased to some extent, the 





This improvement was quite clear with the consistent prediction results 
obtained using the laboratory mixed static models which could be due to static 
powder on the NIR sensor.  
 Prediction results of MgSt 
In the case of MgSt, little difference was observed between the prediction 
performances of the three models. The improved performance of MgSt models 
could be attributed to the tendency of MgSt particles to form a thin adhesive 
film over the coarse excipient particles, ultimately undergoing rapid ordered 
mixing.  This ordered mixing actually nullified the effect of low concentration 
of MgSt and enabled its more uniform distribution throughout the powder bed.  
In summary, for study III-A, significant differences in prediction 
performances were observed when the MVC models were prepared using 
different strategies. Findings of this study indicated the need for maintaining 
similar sampling strategies while preparing and using the prepared MVC 
models for predictions.  
110 
 
 4.3.4. Study III-B: Alternative approach for robust and more 
sensitive MVC models for powder blending 
As revealed from the findings of the Study III-A, maintaining similar 
strategies for spectral acquisition during calibration and real time predictions 
is of paramount importance. However, adopting the same strategies at a larger 
scale such as real time manufacturing is not a feasible option mainly because 
manufacturing companies cannot afford to have production batches with 5 or 6 
different levels of formulation variables (a pre-requisite for generating robust 
and sensitive MVC models). One can use the out of specification production 
batches to build the MVC models, but again it is very highly unlikely to obtain 
the broad range of calibration samples from such situations. Hence, an attempt 
was made to develop MVC models from laboratory mixed samples which 
could bear the prediction ability of the models prepared using real time 
process conditions. 
4.3.4.1. MVC model development 
In the present investigation to impart in-built variability and robustness to 
MVC models, a simplex lattice design which resulted in 126 different 
combinations of blend components was used. Each calibration data set was 
generated from the average of 40 subsequent spectra obtained from each of 
126 samples. Averages of each sample were used to obtain the spectrum 
representative of the overall composition of the powder sample. Considering 
the differences in particle sizes of the blend components (fine μCPM, MgSt 
and coarse lactose, MCC), it was imperative to pre-process the spectra for 
removal of the scattering and baseline offsets effects (Bellamy et al., 2008). 





The raw and pre-processed NIR spectra of each of the blend components in 
pure form are depicted in Figures 16A and 16B. The raw and the pre-
processed spectra of the calibration samples used for model development are 





Figure 23: NIR spectra of calibration samples used for MVC model 
development (A) Raw average spectra, (B) SNV followed by 1st derivative 
pre-processed spectra. In these plots, X and Y axes represent the wavelength 
and absorbance, respectively. 
 
Independent PLS models were calculated for all blend components from the 





calibration samples used in this study consisted of multi-components, a further 
check into the efficiency of the models was carried out by comparing the 
corresponding scores and loadings plots (Figure 24) obtained with each MVC 
model. In these plots, two PCs were used to explain the relationship between 
the spectra and corresponding concentration of each blend component. The 
scores plots showed clear difference and separation between the spectra of the 
6 different levels of calibration samples. On the other hand, loadings plots 
obtained for each model for PC 1 and PC 2 revealed that the models explained 
a major portion of variance (more than 90%) within the calibration samples. 
This indicated the NIR models were adequately accurate and sensitive for 
quantitative estimation of all the blend components. This was further 
supported by the model statistics i.e. X (NIR spectra) and Y (reference values) 
explained variance, RMSEC, standard error of calibration (SEC) and R2 as 
depicted in Table 13. The standard error of cross validation (SECV) and 
RMSECV values obtained from internal validation performed using full cross 
validation showed the sensitivity of the MVC models in predicting the content 
of the blend components.  
External validation results obtained with 22 independent samples are depicted 
in Table 14. Prediction results obtained were compared with reference 
gravimetric values using a paired t test at the 95% confidence interval. Results 
obtained did not show any statistical difference between the MVC model 
predicted and reference values obtained gravimetrically and further confirmed 






Figure 24: 2D scatter scores and loading plots of the SNV and 1st derivative pre-processed calibration spectra of (A) μCPM, (B) 
lactose, (C) MCC and (D) MgSt. In scores plots, Ln represents the level of the component used in preparation of calibration 




Figure 24 (Continued): 2D scatter scores and loading plots of the SNV and 1st derivative pre-processed calibration spectra of (A) 
μCPM, (B) lactose, (C) MCC and (D) MgSt. In scores plots, Ln represents the level of the component used in preparation of 





    
 
 
Figure 24 (Continued): 2D scatter scores and loading plots of the SNV and 1st derivative pre-processed calibration spectra of (A) 
μCPM, (B) lactose, (C) MCC and (D) MgSt. In scores plots, Ln represents the level of the component used in preparation of 
calibration sample. In loadings plots, black and gray dotted curves represent the X loading weights for PC1 and PC2, respectively. 
116 
 
   
 
Figure 24 (Continued): 2D scatter scores and loading plots of the SNV and 1st derivative pre-processed calibration spectra of (A) 
μCPM, (B) lactose, (C) MCC and (D) MgSt. In scores plots, Ln represents the level of the component used in preparation of 






Table 13: Statistics obtained for MVC model of each blend component with 
PLS regression method 
 











X Y R2 RMSEC SEC  RMSECV SECV
μCPM 2  97.52 97.59 0.986 0.442 0.444  0.456 0.459 
lactose 4  98.41 94.14 0.962 0.594 0.597  0.730 0.734 
MCC 4  98.48 90.60 0.971 0.547 0.550  0.709 0.713 
MgSt 3  97.87 90.96 0.987 0.075 0.075  0.083 0.084 
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  Table 14: Results of the external validation blend samples 
 
Blend components (% w/w) 
μCPM   lactose MCC  MgSt  
Batch 
 
REF NIR  REF NIR REF NIR  REF NIR 
1 0.000 0.023  80.000 75.947 20.000 24.420  0.000 0.068 
2 0.000 -0.401  76.000 75.307 24.000 25.260  0.000 -0.002 
3 4.000 4.101  76.000 76.156 20.000 20.148  0.000 0.020 
4 0.000 -0.285  74.000 73.870 26.000 26.518  0.000 -0.003 
5 6.000 6.514  74.000 75.116 20.000 18.315  0.000 0.041 
6 0.000 -0.655  70.000 67.580 30.000 33.128  0.000 0.012 
7 4.000 3.704  70.000 69.119 26.000 28.173  0.000 -0.007 
8 10.000 9.820  70.000 70.931 20.000 19.714  0.000 0.050 
9 3.980 3.635  69.652 70.565 25.871 24.733  0.498 0.412 
10 0.000 0.141  79.602 79.369 19.900 20.550  0.498 0.473 
11 5.970 6.586  69.652 70.202 23.881 23.800  0.498 0.516 
12 9.926 9.280  69.479 69.474 19.851 19.816  0.744 0.694 
13 0.000 0.103  75.434 75.579 23.821 24.343  0.744 0.644 
14 3.970 3.148  75.434 75.474 19.851 19.807  0.744 0.743 
15 0.000 -0.181  69.479 71.382 29.777 27.662  0.744 0.692 
16 9.877 9.362  69.136 67.210 19.753 20.479  1.235 1.267 
17 0.000 0.293  69.136 70.352 29.630 28.830  1.235 1.133 
18 0.000 0.075  73.086 75.254 25.679 23.591  1.235 1.156 
19 5.926 6.353  69.136 68.242 23.704 23.564  1.235 1.255 
20 5.926 6.182  73.086 72.316 19.753 19.725  1.235 1.234 
21 0.000 0.152  79.012 79.403 19.753 19.182  1.235 1.182 
22 3.951 4.660  69.136 70.891 25.679 25.569  1.235 1.244 
Mean 3.342 3.300  72.748 72.715 23.314 23.515  0.596 0.583 
SD 3.595 3.593  3.736 3.602 3.634 3.844  0.526 0.507 
RMSEP 0.455   1.546  1.721   0.047  
t value 0.458   0.105  -0.609   1.271  
p value 0.651   0.917  0.549   0.218  
 
* p value greater than 0.05 indicates two means are similar. REF refers to the 
reference values calculated gravimetrically and NIR refers to the values 
predicted by MVC model. SD and RMSEP refer to the standard deviation and 





4.3.4.2. Application MVC models for real time monitoring of blending 
unit operation  
 In-line quantification of blend components  
According to the recommendations in the Parenteral Drug Association 
technical report on “Blend uniformity analysis”, it is essential to report the 
active ingredient quantity in a sample size varying between one to three unit 
doses (Berman et al., 1997a). Although the aim of this study was to 
quantitatively estimate the distribution of all blend components, μCPM 
concentration equivalent to a unit dose of 500 mg was considered to determine 
the number of spectra to be used to calculate the average unit dose. Based on 
the manufacturer’s (Carl Zeiss) recommendations and the density of the 
powder blend, it was estimated that the 30 mm diameter optical head can 
measure a mass of approximately 250-300 mg (i.e. one spectrum measures the 
powder mass equivalent to 250-300 mg). Hence, an average of three 
consecutive spectra was used to assign a single data point. Thus, the mass 
measured by three NIR spectra (approximately 750-900 mg) was well within 
the standard limit recommended. The respective relative standard deviation 
(RSD) values for each component were calculated from the quotient of the 
standard deviations and the average values of each component obtained from 
every subsequent three spectra. Thus, a total of 100 data points (% RSD 
values) were calculated for preset blending of 300 rotations. In this study, the 
blend components were considered uniformly mixed when their mean 
concentration values were in the range of 100 ± 5% of the target values and 
the corresponding % RSD values below 6 %.      
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  Effect of premixing and prism on mixing of blend components 
The NIR spectra of the blends A, B and C collected during the preset blending 
time are shown in Figure 25. Visual inspection of these spectra showed that 
blend C exhibited highly scattered spectra compared to blends A and B. On a 
qualitative basis, it could be said that blend B showed rapid attainment of 
uniformity of blend components followed by blend A. In contrast, NIR spectra 
of blend C was highly scattered indicating highly variable blend composition 
throughout the blending process. Thus, it was apparent that the prism 
attachment in the IBC significantly enhanced the blending performance of the 
IBC bin blender after high shear premixing. However, use of the prism alone 
without the initial high shear premixing proved inefficient to uniformly blend 
the mixture in the IBC.  Plots of % RSD versus number of rotations for each 
of the blending experiments clearly showed that premixing and prism 
attachment had affected the distribution of not only the μCPM but also the 
excipients (Figure 26). As can be seen from Table 15, a large variation in 
number of rotations required for the blend components to attain blend 
uniformity was observed. Distribution of blend components was very rapid for 
blends A and B. Almost all blend components achieved uniform distribution 
after 20-40 rotations of the blender as evident from their low % RSD values. 
However, for blend C, with the exception of MgSt, none of the other blend 
components had distributed uniformly after the preset blending process.  High 
shear imparted during premixing of blends A and B helped to uniformly 
disperse the relatively smaller size drug particles and also caused the de-
agglomeration of the larger agglomerates. This could be attributed to the 





(shear forces) during the mixing process and can thus perform better for 
mixing of cohesive powders regardless of total mixing time (De Villiers, 1997, 





Figure 25: Raw NIR spectra of the blends collected during the blending 
process (A) blend A, (B) blend B and (C) blend C. In these plots X, and Y axes 







Figure 25 (continued): Raw NIR spectra of the blends collected during the 
blending process (A) blend A, (B) blend B and (C) blend C. In these plots X, 
and Y axes represent the wavelength and absorbance, respectively. 
 
Similar findings were reported by De Villers (1997) in a study which showed 
that the overall de-agglomeration of micro-fine furosemide particles in binary 
mixture increased with increased mixing speed and was more rapid in a higher 
shear turbula mixer compared to the lower speed V-blender. 
Thus, ordered mixing of μCPM particles was expected during premixing 
which would have left the lactose particles coated by the μCPM particles. This 
was apparent from the scanning electron micrographs (Figure 27) which 
showed almost uniform coating of the surfaces of the lactose particles by 






































Figure 26: Comparative assessment of uniformity of blend components (A) 
μCPM, (B) lactose, (C) MCC and (D) MgSt from blends A, B and C. Dotted 
line (-----) represent the % RSD value of 6%. For the sake of clarity, the % 





































Figure 26 (Continued): Comparative assessment of uniformity of blend 
components (A) μCPM, (B) lactose, (C) MCC and (D) MgSt from blends A, B 
and C. Dotted line (-----) represent the % RSD value of 6%. For the sake of 







Table 15: Comparative illustration of the number of rotations required for the 
blend components to attain uniformity 
 
Number of rotations to attain uniformity 
Blend components 
Blend A Blend B Blend C 
μCPM 18 12 X 
lactose 12 9 X 
MCC 24 12 X 
MgSt 21 15 54 
 
 *X indicates the failure of components to distribute uniformly after the preset 
blending time. The blend components were considered uniformly mixed when 
their mean concentration values were in the range of 100±5% of target values 
and the corresponding % RSD values below 6%. 
 
μCPM agglomerates were not obvious on the surfaces of the lactose particles 
after premixing in the high shear mixer (blend A) compared to those premixed 
using sieving (blend C), which showed slight coating effect of μCPM particles 
on the surfaces of lactose particles. Moreover, some random agglomerates as 
large as 1-3 mm were also present in blend C when observed visually at the 
end of the blending process. It was postulated that the large agglomerates 
could be the result of opportunistic aggregation of μCPM particles during the 
blending process as the sieving of powders through the 355 μm aperture size 
sieve did not aid in dispersing the μCPM particles as efficiently as high shear 
mixer during the premixing step. This was again evident from the prediction 
of the comparatively higher than theoretical concentration of μCPM in the 
blend throughout the preset blending time which could be the result of the 
predominant intra-reflection phenomenon exhibited by μCPM particles while 
in the agglomerate state. Thus, for blend C, NIR light had encountered a 
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 greater number of μCPM particle boundaries than that of the rest of the other 
blend components.  
Interestingly, between blends A and B, blend B performed better in terms of 
uniformity in distribution of the blend components. All blend components 
from blend B exhibited lower % RSD throughout the blending period as 
compared to those from blend A. Improved mixing obtained for blend B could 
possibly be due to the increased rate of powder turnover and increased 
occurrences of failure regions with the prism attachment in the IBC 
(Castellanos et al., 1999). The divisive action caused by the prism enabled 
rapidity in uniform distribution of all the blend components in blend B. 
 
Figure 27: Scanning electron micrographs of the lactose particles after 
premixing with μCPM at 1000X magnification: (A) Premixing using high 
shear mixer, (B) Premixing using sieving. 
 
These results were in good agreement with the findings reported by Sudah et 
al. (Sudah et al., 2002) that the attachment of the prism in the IBC had 
positively affected the attainment of blend uniformity for cohesive powder 
blend formulations. Avalanche flow experiments on the blended powders also 





underlying attributes for the behavior of these three powder blends. The 
avalanche flow properties of the blends were as depicted in the strange 
attractor plots (Figure 28). The AFI values for blends A, B and C were 26.8, 
30.5 and 28.1, and the CoI values for the same blends were 0.019, 0.019 and 






Figure 28: Strange attractor plots (A) blends A, (B) blend B and (C) blend C.  
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 Blend B exhibited a rather similar but more condensed strange attractor plot 
than blend C while blend A exhibited the most scattered strange attractor plot. 
The AFI values also showed similar trend, with blend B exhibiting the highest 
AFI value, thus confirming its better flow properties.  
The uniformity of the powder composition in terms of size and density in 
blend B had allowed better powder flow than blend C. A slight reduction of 
μCPM agglomerate size by the prism during blending was anticipated, and 
these smaller agglomerates acted as a glidant by depositing as a fine coat over 
the surfaces of coarse excipients making them smooth and ultimately 
improving the flow property of the bulk powder.  
However, in the case of blend C, the improved flow properties compared to 
blend A could be traced to the initial presence of large μCPM agglomerates, 
which behaved like coarse particles and thus showed good bulk flow. This 
finding agreed well with the finding reported by Soh et al (2006), where the 
improved flow property of finer 450M lactose powders was attributed to the 
presence of transient loosely packed agglomerates within the bulk powder 
mass during avalanching.  
Despite its relatively good flow property, blend C showed highly variable 
distribution of μCPM and coarse excipients except for MgSt. As discussed 
previously, inadequate dispersion of μCPM particles and their opportunistic 
agglomeration into bigger clumps resulted in a rather highly non-uniform 
texture blend in terms of density and size (Sudah, 2002). Interestingly, it was 
observed that MgSt in all blends tended to distribute uniformly. Overall, 





in the IBC with the prism attachment, helped to achieve rapid and uniform 
distribution of blend components.  
 Blend uniformity using UV spectroscopic method 
Blend A and B met the USP blend uniformity criteria for drug content.  Blend 
C failed the uniformity criteria as the mean content and %RSD values were 
not within the standard range.  Moreover, the assay value of drug for blend C 
was relatively higher, indicating the abundance of agglomerates in the blend 
even after the 30 min blending period. Higher content of drug could be 
attributed to the better flow properties of agglomerates compared to the 
primary drug particles and excipients. This improved flow actually led to the 
filling of the sampling cavity of the sampling thief with more of the drug 
agglomerates than the whole blend composition. 
In summary, findings of this study demonstrated that with the usage of more 
complex experimental design and changes in the formulation strategy, it is 
possible to develop accurate and sensitive MVC models from the samples 




 4.3.5. Study III-C: Monitoring of tabletting unit operation 
4.3.5.1. Effective surface area sampled by NIR probe 
Effective tablet surface area sampled by the NIR probe was determined based 
on the distance travelled by the moving tablet under the illuminated spot of 
3.18 mm diameter of the NIR probe. Considering the experimental conditions 
used, it was estimated that the 3.18 mm spot would traverse a distance of 1.66 
mm during its scanning across the tablet surface. Thus, the effective surface 
area, i.e. area sampled by the NIR probe, was 13.221 mm2. There was an 
added advantage of employing dynamic sampling (moving tablets) as it 
actually enabled the scanning of a larger tablet surface than a stationary 
illuminated spot measurement of 3.18 mm diameter. Furthermore, with the 
usage of this dimension, it was possible to determine the occurrence of non-
uniform distribution resulting from the agglomeration of very fine μCPM 
particles (3 μm) which would not have been feasible with analysis of the 
whole area of the tablet surface. In a recent investigation, Li et al. (2003) 
demonstrated that spectral analysis of a small part of the tablet is an acceptable 
replacement for whole tablet analysis using traditional HPLC/UV. 
4.3.5.2. Effect of sampling strategies on NIR spectra 
Preliminary experiments were carried out to examine the effect of sampling 
strategies on the NIR spectral features of the tablets. Target formulation tablets 
compressed using a rotary press were subjected to NIR spectral acquisition 
using static and dynamic strategies. Dynamic spectral acquisition was carried 
out in real time during the process, whereas for static spectral acquisition, 
tablets were scanned manually by placing them underneath the probe on a 





followed by 1st derivative pre-processing. Careful examination of the spectra 
(Figure 29) obtained using different strategies showed the exhibition of 
spectral differences. The observed spectral differences illustrated the 
importance of adopting appropriate and similar sampling strategies for both 
calibration and actual testing, i.e. real time tabletting process. Hence, it was 
decided to capture the NIR spectra of the calibration tablets in a dynamic 




Figure 29: Spectral differences observed with NIR spectra of tablets between 
the sampling strategies. In these plots, X and Y axes represent the wavelength 
(nm) and absorbance, respectively.  
 
4.3.5.3. MVC model development  
Figures 30A and 30B showed the raw and SNV followed by 1st derivative pre-
processed spectra of calibration tablets for the entire spectral range of 980-
1900 nm. Performances of the models were compared on the basis of 
calibration statistics as shown in Tables 16 and 17. All the models built using 
respective signature wavelengths for each of the blend components showed 
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 inferior performance in terms of calibration statistics, irrespective of the 






Figure 30: NIR spectra of calibration batch tablets. (A) Raw and (B) SNV 
followed by 1st derivative pre-processed. In these plots, X and Y axes 





Table 16: Statistics obtained for MVC model of each blend component with 
PLS regression method based on SNV followed by 1st derivative pre-
processed spectra 
 
Explained variance (%)  Calibration 
Components 
No. of 
PC X Y  R2 
RMSEC   
(%) 
RMSECV   
(%) 
Spectral region 980-1900 nm  
μCPM 4 90.00 94.92  0.961 0.572 0.603 
lactose 6 90.27 90.66  0.942 0.696 0.797 
MCC 6 91.12 88.22  0.927 0.797 0.904 
MgSt 4 91.08 94.12  0.947 0.080 0.084 
Martens’ jack-knifing  
μCPM 4 90.62 94.90  0.952 0.585 0.604 
lactose 6 91.25 90.06  0.914 0.847 0.909 
MCC 6 91.15 87.50  0.915 0.863 0.958 
MgSt 4 90.61 84.02  0.845 0.137 0.139 
Spectral region 980-1400 nm  
μCPM 9 90.15 90.94  0.937 0.669 0.676 
lactose 5 90.00 75.32  0.831 1.211 1.322 
MCC 5 93.75 71.63  0.853 1.138 1.289 
MgSt 5 90.96 84.22  0.868 0.126 0.131 
Spectral region 1400-1900 nm  
μCPM 5 90.01 92.75  0.934 0.675 0.711 
lactose 6 90.74 84.01  0.864 1.064 1.157 
MCC 5 90.59 79.64  0.880 1.036 1.188 
MgSt 5 91.85 91.92  0.939 0.085 0.089 
Signature wavelengths (MLR)  
μCPM - - -  0.871 0.919 0.923 
lactose - - -  0.615 1.629 1.636 
MCC - - -  0.740 1.538 1.551 
MgSt - - -  0.867 0.128 0.129 
 
*PC represents principal components, R2: correlation coefficient, RMSEC: 
root mean square error of calibration; RMSECV: root mean square error of 
prediction obtained with leave one out full cross validation. Martens’ jack-
knifing indicates the PLS models built using significant wavelengths 




 Table 17: Statistics obtained for MVC model of each blend component with 
PLS regression method based on SNV followed by 2nd derivative pre-
processed spectra 
 
Explained variance (%)  Calibration 
Components 
No. of 





Spectral region 980-1900 nm 
μCPM 6 69.85 89.53  0.916 0.867 0.969 
lactose 8 69.71 85.74  0.911 0.845 1.074 
MCC 8 68.95 76.84  0.829 1.179 1.374 
MgSt 6 68.97 91.77  0.930 0.090 0.098 
Martens’ jack-knifing 
μCPM 4 62.65 91.86  0.924 0.817 0.847 
lactose 8 68.37 79.99  0.843 1.146 1.292 
MCC 7 70.77 78.16  0.821 1.205 1.335 
MgSt 5 71.53 91.50  0.922 0.096 0.099 
Spectral region 980-1400 nm 
μCPM 5 72.90 93.18  0.937 0.720 0.750 
lactose 7 74.01 82.73  0.856 1.130 1.239 
MCC 7 71.83 79.73  0.836 1.191 1.326 
MgSt 7 75.33 84.61  0.864 0.127 0.135 
Spectral region 1400-1900 nm 
μCPM 5 68.24 88.84  0.900 0.877 0.928 
lactose 8 68.85 82.91  0.874 1.006 1.176 
MCC 7 67.18 82.62  0.868 1.055 1.211 
MgSt 6 68.90 91.42  0.927 0.093 0.101 
Signature wavelengths (MLR) 
μCPM - - -  0.827 1.275 1.283 
lactose - - -  0.808 1.334 1.342 
MCC - - -  0.798 1.352 1.360 
MgSt - - -  0.734 0.158 0.159 
 
*PC represents principal components, R2: correlation coefficient, RMSEC: 
root mean square error of calibration; RMSECV: root mean square error of 
prediction obtained with leave one out full cross validation. Martens’ jack-
knifing indicates the PLS models built using significant wavelengths 






This was quite interesting as most previous studies based on static spectral 
acquisition reported improved performances of models after restricting the 
wavelengths to where the specific regions were. In static acquisition, 
occurrence of spectral shifts is unlikely as the calibration sample/tablet surface 
is always stationary under the probe during measurement as compared to 
dynamic acquisition where the calibration sample is subjected to continuous 
movement during measurement. Hence, inferior performances of models built 
using signature wavelengths could be attributed to the spectral shift. 
In the case of PLS models built using different wavelength ranges, the 
performances of MVC models were found to be better when SNV followed by 
1st derivative spectra was used. Y explained variances for all the models 
reduced, particularly when they were built using SNV followed by 2nd 
derivative spectra. However, models built using significant wavelengths 
obtained after Martens’ jack-knife significance test resulted in somewhat 
similar performances compared to those built using full wavelength range. The 
largest RMSEC and RMSECV were observed for the low wavelength region 
(980-1400 nm). Moreover, X and Y explained variances with models 
developed using narrow ranges (both 980-1400 and 1400-1900 nm) were 
inferior compared to those using entire wavelength range.  
The improved performance with the entire wavelength range models could be 
attributed to the incorporation of multivariate data averaging effect where 
regions/wavelengths even with the slightest correlation were also utilized for 
model development (Beebe et al., 1998). Previous studies have shown the 
improved performance of MVC models after narrowing down the wavelength 
range (El-Hagrasy and Drennen III, 2006). However, for the present study, an 
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 opposite trend was observed, possibly due to the wider spread of the high 
correlation regions / wavelengths of the analytes (tablet components). These 
results concurred with the findings reported by Meza et al. (2006) where they 
attributed the improved performance of the MVC model to the inclusion of 
many wavelengths with slightest correlation while building the calibration 
models. Based on this finding, the MVC model for each component included 
the entire spectral range, i.e. 980-1900 nm, pretreated with SNV followed by 
1st derivative spectral pre-processing.  
Among the models involving the entire spectral range, the μCPM and MgSt 
models showed excellent results in terms of explained variances and residual 
errors at the calibration and validation stages. This could be attributed to the 
action of dry powder coating of the coarse excipients by the numerically 
larger, fine μCPM and MgSt particles during mixing of the blend components. 
Thus, the measuring head encountered the μCPM and MgSt boundaries at a 
much higher frequency than those of the coarser lactose and MCC. 
4.3.5.4. Validation according to ICH guidelines  
As the MVC models were developed based on dynamic spectral data, it was 
imperative to test the adequacy and applicability of the model for process 
analysis. The proposed NIR method was validated in accordance with the ICH 
guidelines for accuracy, repeatability, intermediate precision and linearity 
(ICH, 2005).  
 Linearity        
The linearity of an analytical method can be defined as its ability, within a 
given range, to predict the concentration of test (unknown) samples which are 





Linearity was confirmed on the basis of the R2 values of regression lines 
obtained from the plots of MVC model predicted values and reference values 
at the calibration and test set validation stages. Figure 31 depicts the predicted 
vs. measured plot for each tablet component. All the models were found to 
exhibit linearity within the span of calibration and validation range as 





Figure 31: MVC models for (A) μCPM, (B) lactose, (C) MCC and (D) MgSt. 
Points in blue color in the regression plots indicate the calibration samples 








Figure 31 (continued): MVC models for (A) μCPM, (B) lactose, (C) MCC and 
(D) MgSt. Points in blue color in the regression plots indicate the calibration 







Table 18: Validation results obtained with the leave one out full cross 
validation and test set validation 
 
μCPM  lactose  MCC  MgSt 
Statistics 
FCV TSV  FCV TSV  FCV TSV  FCV TSV 
Samples  105 34  105 34  105 34  105 34 
Bias -0.001 -2.891  -0.001 0.214  -0.001 0.458  0.000 0.013
R2 0.949 0.944  0.924 0.887  0.906 0.903  0.941 0.926
RMSE (%) 0.603 0.869  0.797 0.844  0.904 0.800  0.084 0.097
SDR (%)   0.453   0.902   0.785   0.081
 
* FCV: leave one out full cross validation statistics, TSV: test set validation 
statistics, SDR: standard deviation of residuals. 
 Accuracy 
Accuracy of the models developed was estimated based on RMSECV and bias 
values obtained from the leave one out full cross validation and on RMSE 
(root mean square error of prediction with test set) and bias values obtained 
from the test set validation. Results obtained for RMSECV, RMSE and bias 
values confirmed the accuracy of the models for predicting the concentration 
of tablet components. A further estimate of accuracy for each component was 
given by the standard deviation of the residuals obtained after the test set 
validation (Table 18). 
 Repeatability 
Repeatability, an indicator of precision under the same conditions over a short 
interval of time, was assessed according to the ICH specifications which 
require: (a) a minimum of 6 readings of a single sample at 100% target 
concentration, and (b) a minimum of 3 samples, one at each of the 3 levels of 
concentration.  
 Table 19: Results of repeatability and intermediate precision 
 
Tablet 1   Tablet 2   Tablet 3  
Statistics μCPM lactose MCC MgSt  μCPM lactose MCC MgSt  μCPM lactose MCC MgSt 
 Repeatability 
Mean  (% w/w) 2.55 70.73 27.45 1.11  4.40 69.86 28.19 1.10  6.13 69.24 31.98 0.96 
% RSD 0.96 0.30 0.91 1.39  0.59 0.33 0.68 1.19  0.63 0.24 0.77 1.96 
 Intermediate precision 
Inter day               
p value 0.37 0.60 0.49 0.93  0.70 0.37 0.85 0.51  0.83 0.64 0.44 0.81 
F experiment 1.70 0.67 0.15 0.08  0.44 1.68 0.18 0.95  0.21 0.58 1.28 0.24 
F critical 19.00 19.00 19.00 19.00  19.00 19.00 19.00 19.00  19.00 19.00 19.00 19.00 
Inter analyst               
p value 0.37 0.60 0.49 0.29  0.37 0.64 0.29 0.20  0.97 0.11 0.25 0.88 
F experiment 4.12 2.57 0.70 2.04  1.32 0.30 2.09 3.67  0.00 7.80 2.60 0.03 











Tablets with μCPM concentration at 3 levels were used. Each tablet was 
scanned and 10 spectra per tablet were obtained and the concentration of each 
component was predicted using respective MVC models. % RSD values of 
lower than 2 were obtained for all the tablet components (Table 19) indicating 
that there was adequate exhibition of repeatability of predictions by the 
models applied. 
 Intermediate precision  
Intermediate precision, an indicator of precision under the influence of random 
events during the analysis, was determined by analyzing tablets for μCPM 
concentration at 3 levels on two different days and by two analysts, each 
carrying out the analysis on a different day. Results of the intermediate 
precision studies are as shown in Table 19. Two factor ANOVA was 
performed on the data and it did not show any statistically significant 
differences between analysts and days for tablet testing.  
4.3.5.5. Application of MVC models for real time monitoring of 
tabletting unit operation 
 System performance for real time application  
Results obtained from the initial calibration and validation studies confirmed 
the accuracy of the developed MVC models to predict the concentration of the 
tablet components. However, the next objective was to apply the developed 
models for their application in real time monitoring during the tabletting 
process. Considering the differences between the tablets prepared at the 
calibration stage by a hydraulic press and production stage by a rotary press, 
the occurrence of spectral artefacts was anticipated. These artefacts could be 
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 detrimental to cross correlation studies and may lead to erroneous predictions. 
Hence, it was imperative to standardize the measured spectra in order to 
minimize the incorporation of process borne effects during predictions. A 
possible treatment to minimize such differences was to standardize the spectral 
acquisition times during the calibration and production stages and to pre-
process the spectra with suitable pre-processing techniques which had been 
shown to be able to minimize such effects. A fixed integration time of 100 ms 
for spectral acquisition and different pre-processing were adopted at the 
calibration and production stages of analyses. Batches of tablets with μCPM 
concentration at 6 levels (0% w/w, 2% w/w, 4% w/w, 6 % w/w, 8% w/w and 
10% w/w) were prepared independently using the hydraulic press and rotary 
press. After compression using the hydraulic press, the NIR spectra of tablets 
were obtained according to the procedure described for calibration tablets.  
Rotary press tablets were scanned in-line during tabletting. Efficiency of the 
conditions was tested by analyzing the spectra using PCA and by comparing 
predictions of content of individual formulation components using the 
respective models (Figure 32). For PCA, the spectra were normalized using 
1/standard deviation scaling so as to bring the scores to equal scales. Among 
the different pre-processings used, SNV followed by 1st derivative showed 
excellent results in terms of reducing the effects arising from differences in the 
compression process employed as evident from the reduced scattering within 
the scores plots. The distance between the scores of the tablets of the same 
formulation but compressed using hydraulic and rotary process was found to 
be reduced in the scores plot obtained from pre-processed spectra. 







tablet component revealed no statistically significant differences between 
tablets compressed using the hydraulic press and rotary press (p value > 0.05 





Figure 32: Scores plots for the spectra obtained after PCA. (A) Raw spectra 
and (B) Spectra treated with SNV followed by 1st derivative. S-n represents 
the tablets compressed using hydraulic press and D-n represents the tablets 
compressed using rotary press. 
 Table 20: Effect of compression process on the prediction results obtained from MVC models 
 
Tablet component (% w/w) 
μCPM Lactose MCC MgSt 
Tablet 
formulation 
Ref Rotary Hydraulic Ref Rotary Hydraulic Ref Rotary Hydraulic Ref Rotary Hydraulic  
1 0.000 -0.408 -0.019 69.301 73.010 72.044 29.703 30.982 32.086 0.990 1.140 0.990 
2 1.980 1.919 1.967 77.222 78.688 76.355 19.802 19.763 21.743 0.990 0.982 0.968 
3 3.960 4.302 4.822 73.267 73.475 74.048 21.782 22.104 22.869 0.990 1.007 0.894 
4 5.941 6.632 6.408 71.287 70.802 69.720 21.782 22.516 20.132 0.990 0.921 0.937 
5 7.921 8.029 8.254 71.287 71.909 72.414 19.802 18.281 16.864 0.990 1.192 0.901 
6 9.901 11.503 11.486 69.301 66.346 63.861 19.802 18.075 21.979 0.990 1.112 1.052 
Mean  5.330 5.486  72.372 71.407  21.954 22.612  1.059 0.957 
p value  0.221   0.134   0.511   0.074  
 
“Ref” indicates gravimetric reference values of the tablet components “Rotary” and “Hydraulic” indicate the NIR predicted 






 In-line analysis of tablets  
In-line quantification of the formulation components during tabletting was 
carried out using the setup described in the experimental section. The rotary 
tabletting machine was operated at 10 rpm which ultimately resulted in the 
production rate of 100 ± 3 tablets/min. Considering the tabletting speed, an 
integration time of 100 ms was adequate for scanning a sufficient area of one 
tablet at each trigger. In-line spectral acquisition was carried out over 100 min. 
Thus, approximately 10,000 tablets were scanned during the acquisition 
process. The spectral data was divided into three periods of the tabletting 
operation, i.e. 0-30 min, 30-60 min and 60-100 min, in order to determine any 
deviation in content uniformity during the tabletting process. Frequency 
distribution plots (Figure 33) for μCPM per period were constructed from the 
individual prediction values obtained. One of the major limitations for the 
analysis of the data in the present study was the non-existence of scale of 
scrutiny guidelines for excipients unlike for the active component in the 
formulation. For ease of analysis, only the active, i.e. μCPM, was subjected to 
the USP specified scale of scrutiny. However, it was recognized that a casual 
check of concentration values would also be useful to mark the occurrence of 
non-uniform distribution of excipients within the powder blend in the hopper 
during the tabletting process. Mean μCPM concentration of the tablets and % 
RSD values for each component obtained from in-line predictions are depicted 
in Tables 21 and 22.  The highest and lowest concentrations of μCPM were 
114.63 % and 85.06 % during the first 30 min. These results passed the USP 
criteria (2009) of 100 ± 15 % content and % RSD of not more than 6%, 
confirming that the drug particles were uniformly distributed in the tablets.  
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Figure 33: Frequency distribution plots of individual tablet potency in terms of μCPM obtained from (A-1 to A-3) in-line NIR, 
(B1 to B3) stratified NIR and (C1 to C3) stratified UV analysis. The numbers 1, 2 and 3 indicate the time periods of 0-30, 30-60 







Table 21: Comparison of μCPM (% potency) prediction results by in-line NIR, stratified NIR and stratified UV sampling 
 
Mode In-line NIR  Stratified NIR  Stratified UV 
Time (min) 0-30 30-60 60-100  0-30 30-60 60-100  0-30 30-60 60-100 
Minimum 85.06 80.18 76.23  97.55 87.23 84.38  95.39 85.33 85.23 
Maximum 114.63 118.94 127.84  111.78 112.80 112.73  110.55 111.85 113.81 
OOS  tablets* 0 86 302  0 0 1  0 0 0 
Mean 101.05 98.38 92.19  104.60 101.83 99.60  103.02 107.10 100.26 
% RSD 5.96 6.98 6.81  4.47 6.12 8.19  4.48 5.12 6.55 
 
* OOS represents tablets out of specification of USP standard criteria.   
 Table 22: Summary of NIR prediction results (% potency) obtained from in-line and stratified sampling 
 
Component  lactose MCC MgSt 
Time (min)  0-30 30-60 60-100 0-30 30-60 60-100 0-30 30-60 60-100 
In-line NIR 
Minimum  77.02 76.94 71.69 82.06 86.13 95.94 82.40 83.84 90.64 
Maximum  99.59 97.73 95.51 124.65 125.55 137.47 107.44 131.20 120.40 
Mean  90.48 89.58 88.41 99.12 106.14 112.10 96.70 103.47 106.31 
% RSD  3.29 3.17 2.75 5.88 5.56 4.47 4.08 4.49 2.99 
Stratified NIR 
Minimum  93.66 91.12 83.06 94.89 96.47 94.35 89.37 92.42 89.58 
Maximum  105.06 103.25 99.44 112.13 115.45 115.99 105.68 109.58 110.74 
Mean  97.65 96.79 95.75 103.99 103.34 105.47 98.26 101.32 101.35 






However, deviation in content uniformity was observed midway through the 
tabletting process and deteriorated towards the end stage as can be seen from 
the skewed frequency distribution plots for μCPM (Figure 33A-2 and 33A-3).  
The results of this in-line NIR study revealed the occurrence of segregation 
towards the end of the tabletting process as shown by reductions in mean 
concentrations of both μCPM and lactose and a slight increase in 
concentration of MCC (Tables 21 and 22). This occurrence of segregation in 
an initially well-blended 5 kg powder as used in the present study (even in the 
absence of an unusually high vibration frequency) was due to the considerable 
disparities in the physical characteristics of the blend components, i.e. size and 
density, and the hopper geometry (bin hopper with a tapered end (Figure 5B).  
A non- skewed content uniformity histogram was obtained for the tablets 
compressed during the initial 0-30 min period as depicted in Figure 33A-1. 
During their residence in the hopper, the lactose particles coated with fine 
μCPM particles (Figure 27A) behaved as individual ordered units as they had 
been premixed using a high shear mixer before mixing with the remaining 
excipients in an IBC.  Initially, the powder blend underwent mass flow pattern 
on a first in/first out basis. This particular flow pattern exhibited by the blend 
promoted uniform flow of the blend components for tabletting. As more and 
more of the blend was utilized (30-60 min), a skewed distribution of the 
content uniformity data was obtained (Figure 33A-2). This was attributed to 
the slight change in flow pattern which caused a greater degree of channeling 
at the core region of the powder bed and development of a shallow v-shaped 
powder surface. The v-shaped depression became more pronounced at the 
later stage of tabletting (60-100 min) as can be observed from the severely 
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 skewed distribution of the content uniformity data (Figure 33A-3). The low 
amount of powder blend remaining and the hopper geometry (its funnel shape 
section with tapered end) led to rolling segregation, with the denser ordered 
units (lactose particles coated with μCPM) moving more rapidly downwards 
and the less dense MCC particles trailing behind at the upper portion of the 
powder bed.  
 Simultaneous collection of in-line blend uniformity data of the powder blend 
in the hopper, which was beyond the scope of this study, would be useful to 
demonstrate and confirm this occurrence of segregation in the hopper. 
Although changes in lactose and MCC concentrations were detected at the 
later stage of tabletting, these changes were still within the scale of scrutiny 
observed in this study (Table 22). This could be traced to their much larger 
proportions in the blend/tablet matrix composition. As for MgSt, despite being 
present in a lower proportion, it showed uniform distribution due to its 
formation of a thin coat over the coarser excipients.  
 Analysis of tablets using stratified sampling 
Results obtained with stratified sampling for μCPM are as shown in Table 21 
and in the frequency distribution plots in Figure 33 while the results for 
excipients are shown in Table 22. As can be seen from the results for μCPM 
content, both NIR and UV stratified sampling analysis of 30 tablets per time 
period showed that the whole batch met the standard specification for content 
uniformity and did not detect any content non-uniformity within the batch. 
This is because the probability of the tablet batch being passed as within the 
standard specification for content uniformity increases with decrease in 





able to reveal the potential content non-uniformity issues towards the later part 
of the tabletting process. NIR in-line analysis showed significant number of 
tablets starting to fall outside the USP criteria when the batch reached the 
second half of the tabletting cycle. NIR prediction results obtained for 
stratified sampled tablets did not reveal any aberrant distribution phenomenon 
for the excipients. 
4.3.6. Continuous quality monitoring and control of the tabletting 
process 
US-FDA in its PAT guidance (FDA, 2004) encouraged pharmaceutical 
manufacturers to voluntarily develop and implement new technologies in 
pharmaceutical production and quality control for real time measurements of 
critical product and process parameters. PAT implies building quality into 
products through better understanding and control of the manufacturing 
process, rather than merely testing the quality of the end product. With the 
experimental set up discussed in this study, PAT goals of continuous quality 
monitoring of the process could be achieved successfully. As demonstrated, 
this in-line monitoring study may be used to identify out of specification 
(OOS) tablets in real time. This would not have been possible by following 
merely the pharmacopoeial requirement for sampling and testing of 30 tablets 
off-line.  
Additionally, owing to the multi-sensing ability of NIR, it was possible to 
track the in-process distribution of excipients within the tablet matrix. 
Although the problem of non-uniform distribution of excipients was not 
observed due to their relatively larger proportions in the tablet formulation, 





lower proportions of excipients, such as super-disintegrants or release 
modifiers, which are used in much smaller quantities and their uniform 
















 5. CONCLUSION  
In this PhD. project, important aspects concerned with low dose tablet 
manufacturing were studied. Findings obtained gave some insights into the 
role of surface roughness of excipients and advantages of applying NIR 
spectroscopy for inline monitoring of low dose tablet manufacturing process. 
This conclusion section is divided into different segments based on the 
objectives laid at the beginning to prove the hypotheses of the project. In a 
final segment, a brief description on the future direction is also given which 
could add further value to the findings of this project. 
Surface roughness values obtained for different grades of lactose particles, 
using the optical interferometer were in good agreement with those obtained 
with conventional scanning probe microscopy and thus confirmed its 
suitability for routine surface analysis. Moreover, qualitative and quantitative 
analysis using the optical interferometer provided a more accurate and an 
integrated measure for surface roughness measurements of the lactose 
particles. 
Precision coating successfully enabled the surface modification of lactose 
particles with different degree of roughness without essentially altering the 
size and shape of core particles. A linear relationship was exhibited by the 
roughness of lactose particles with the bulk powder flow. When blended with 
the low dose drug, μCPM, capacity of lactose carrier particles to retain drug 
particles decreased with decreasing surface roughness. However, when the 
degree of surface roughness decreased to a certain extent, strong capacity to 





capacity of carrier particles with different surface roughness to retain μCPM 
particles is not a straightforward process.  Carrier particles with rough surfaces 
could have strongly held the drug particles through mechanical interlocking or 
accommodating the drug particles in the void spaces between the lactose 
particles whereas increased area of contact could have accounted for greater 
extent of retention of μCPM particles on the lactose particles with smooth 
surface. Overall, it was found that for low dose drug products surface 
roughness of coarse excipients particles can play an important role upon 
ordered mixing in terms of physical stability, i.e. capacity to withstand powder 
handling procedures. 
Results obtained from NIR application to monitor low dose tabletting 
manufacturing process revealed that with the unique features of NIR, i.e. high 
speed sampling and rapid spectral acquisition, distribution of individual 
formulation components can be assessed with high accuracy during blending 
and tabletting. A NIR sampling paradox resulting from the different strategies 
of spectral acquisition while preparing and implementing the MVC models for 
prediction of blend components was demonstrated. Among the different 
strategies, dynamic sampling and analysis resulted in the best calibration and 
prediction results. For the static MVC models, component concentrations of 
CPM and MCC were consistently predicted to be significantly higher than the 
actual concentrations in the target formulations. For lactose, static MVC 
models resulted in under prediction of the concentration values than in the 
target formulations. Prediction results of MgSt were found to be the least 
affected irrespective of the differences in sampling strategies at calibration and 
real time process analyses due to its fineness and adhesive property. In 
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 summary, prediction errors illustrated the importance of adopting appropriate 
and similar sampling strategies for both calibration and actual testing, i.e. real 
time blending process. 
Findings of the next study demonstrated that with the use of more extensive 
and elaborate experimental design and certain modifications in formulation 
strategies (micronization of drug in this study), it is possible to generate MVC 
models as sensitive and accurate as those prepared using samples obtained 
from the actual process in real time. Adequacy of MVC models for in-line 
quantification of individual blend components was visible from the scores 
plots, loadings plots, RMSECV, SEP and external validation results. 
Furthermore, in-line monitoring of the blends using these MVC models gave 
some insights into the blending process. Results revealed that despite the 
cohesive nature of the blends, due to initial premixing using high shear mixer, 
uniform distribution of blend components was achieved during the early phase 
of the blending process in the IBC. Results obtained from the blending study 
explained the impact of premixing and introduction of the prism attachment in 
IBC on the rapid and uniform distribution of blend components especially that 
of coarse components. However, the gentle sieving process failed to disperse 
the micronized drug particles uniformly, and also hampered the distribution of 
coarse excipients even in the presence of the prism. With the ability of NIR for 
sample acquisition at a very fast rate and its multi-sensing property, it was 
possible to detect discrepancies in the mixing of MCC and MgSt, which in a 
blend took relatively longer to distribute throughout the blend compared to 
μCPM and lactose. This blend would be considered uniformly mixed before 





traditional sense in terms of drug only. Hence, it is imperative to monitor the 
distribution of excipients along with drug especially while dealing with blends 
similar to the one discussed in this study as the rate of uniform distribution of 
blend component is likely to vary based on their physical properties, 
essentially particle size and flow.  
Findings from another study focused on monitoring of the tabletting process 
demonstrated that the unique features of NIR for high speed sampling and 
rapid spectral acquisition enabled the quantification of individual tablet 
components with a high degree of accuracy during tabletting. In-line analysis 
revealed the inadequacies associated with the commonly employed analysis of 
a smaller number of sampled tablets from the production batch. Sampling 
could not consistently identify the content uniformity problems and thus 
warranted the need for increasing the number of tablets to be analyzed before 
allowing the release of a tablet batch in certain cases. In conclusion, spectral 
acquisition at high rate was possible with the in-line sensor, thereby resulting 
in a better understanding of the relative distribution of the excipients within 
the powder blend/tablet which would not have been possible with traditional 
blend/content uniformity analysis. Overall, findings of these studies are a step 
forward towards achieving the objectives laid out by the PAT guidelines.  
Although these studies revealed many important findings, there are still few 
limitations, which could be the subject of future investigation. Additional 
studies investigating the effect of excipient related properties such as effect of 
shape factors (waviness), in ordered mixing of low dose drug product could 
give further insights to improve the ordered mixing process of low dose drugs. 





lactose, which would bear basic differences in their shape factors. For NIR 
spectroscopy, in-process monitoring of granulation processes such as roller 
compaction involving low dose formulations could be carried out. For roller 
compaction, it is possible to gain insights into the effects of formulation and 
processing variables on the quality of compacted ribbons and the granules 
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